
<html lang="en"     class="pb-page"  data-request-id="23eebbda-827a-4d1e-ba0b-d0273a521765"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00873;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases" /></meta><meta name="dc.Creator" content="Montse  Erra" /></meta><meta name="dc.Creator" content="Joan  Taltavull" /></meta><meta name="dc.Creator" content="Francisco Javier  Bernal" /></meta><meta name="dc.Creator" content="Juan Francisco  Caturla" /></meta><meta name="dc.Creator" content="Marta  Carrascal" /></meta><meta name="dc.Creator" content="Lluís  Pagès" /></meta><meta name="dc.Creator" content="Marta  Mir" /></meta><meta name="dc.Creator" content="Sònia  Espinosa" /></meta><meta name="dc.Creator" content="Jordi  Gràcia" /></meta><meta name="dc.Creator" content="María  Domínguez" /></meta><meta name="dc.Creator" content="Mar  Sabaté" /></meta><meta name="dc.Creator" content="Stéphane  Paris" /></meta><meta name="dc.Creator" content="Mónica  Maldonado" /></meta><meta name="dc.Creator" content="Begoña  Hernández" /></meta><meta name="dc.Creator" content="Mónica  Bravo" /></meta><meta name="dc.Creator" content="Elena  Calama" /></meta><meta name="dc.Creator" content="Montserrat  Miralpeix" /></meta><meta name="dc.Creator" content="Martin D.  Lehner" /></meta><meta name="dc.Creator" content="Marta  Calbet" /></meta><meta name="dc.Description" content="Oral PI3Kδ inhibitors such as Idelalisib and Duvelisib have shown efficacy as anticancer agents and Idelalisib has been approved for the treatment of three B-cell cancers. However, Idelalisib has a..." /></meta><meta name="Description" content="Oral PI3Kδ inhibitors such as Idelalisib and Duvelisib have shown efficacy as anticancer agents and Idelalisib has been approved for the treatment of three B-cell cancers. However, Idelalisib has a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 15, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00873" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00873" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00873" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00873" /></link>
        
    
    

<title>Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00873" /></meta><meta property="og:title" content="Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0020.jpeg" /></meta><meta property="og:description" content="Oral PI3Kδ inhibitors such as Idelalisib and Duvelisib have shown efficacy as anticancer agents and Idelalisib has been approved for the treatment of three B-cell cancers. However, Idelalisib has a black box warning on its product label regarding the risks of fatal and serious toxicities including hepatic toxicity, severe diarrhea, colitis, pneumonitis, infections, and intestinal perforation. Some of these side effects are mechanism-related and could hinder the development of Idelalisib for less severe conditions. For respiratory diseases, compounds administered by inhalation are delivered directly to the site of action and may improve the therapeutic index of a drug, minimizing undesired side effects. This work describes the discovery and optimization of inhaled PI3Kδ inhibitors intended for the treatment of severe asthma and COPD. Once the potency was in the desired range, efforts were focused on identifying the particular physicochemical properties that could translate into better lung retention. This medicinal chemistry exercise led to the identification of LAS195319 as a candidate for clinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00873"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00873">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00873&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00873&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00873&amp;href=/doi/10.1021/acs.jmedchem.8b00873" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9551-9567</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00855" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00960" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Montse Erra</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Montse Erra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#7d101213090e1853180f0f1c3d1c1110140f1c1111531e1210"><span class="__cf_email__" data-cfemail="284547465c5b4d064d5a5a4968494445415a494444064b4745">[email protected]</span></a>. Tel.: +34933128714.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Montse++Erra">Montse Erra</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8753-8692" title="Orcid link">http://orcid.org/0000-0002-8753-8692</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joan Taltavull</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joan Taltavull</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joan++Taltavull">Joan Taltavull</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5199-5349" title="Orcid link">http://orcid.org/0000-0002-5199-5349</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco Javier Bernal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco Javier Bernal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+Javier++Bernal">Francisco Javier Bernal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Juan Francisco Caturla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juan Francisco Caturla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juan+Francisco++Caturla">Juan Francisco Caturla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Carrascal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Carrascal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Carrascal">Marta Carrascal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lluís Pagès</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lluís Pagès</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Llu%C3%ADs++Pag%C3%A8s">Lluís Pagès</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3367-9529" title="Orcid link">http://orcid.org/0000-0002-3367-9529</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Mir</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Mir</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Mir">Marta Mir</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sònia Espinosa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sònia Espinosa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%B2nia++Espinosa">Sònia Espinosa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jordi Gràcia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jordi Gràcia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jordi++Gr%C3%A0cia">Jordi Gràcia</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7470-6933" title="Orcid link">http://orcid.org/0000-0002-7470-6933</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María Domínguez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María Domínguez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics and Metabolism, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa++Dom%C3%ADnguez">María Domínguez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mar Sabaté</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mar Sabaté</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics and Metabolism, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar++Sabat%C3%A9">Mar Sabaté</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stéphane Paris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stéphane Paris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=St%C3%A9phane++Paris">Stéphane Paris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mónica Maldonado</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mónica Maldonado</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%B3nica++Maldonado">Mónica Maldonado</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Begoña Hernández</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Begoña Hernández</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry and Screening, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bego%C3%B1a++Hern%C3%A1ndez">Begoña Hernández</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mónica Bravo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mónica Bravo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Area, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%B3nica++Bravo">Mónica Bravo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Calama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Calama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Area, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Calama">Elena Calama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Montserrat Miralpeix</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Montserrat Miralpeix</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Area, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Montserrat++Miralpeix">Montserrat Miralpeix</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin D. Lehner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin D. Lehner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Area, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin+D.++Lehner">Martin D. Lehner</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Marta Calbet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Calbet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Area, Almirall R&D, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Calbet">Marta Calbet</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00873&amp;href=/doi/10.1021%2Facs.jmedchem.8b00873" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9551–9567</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 June 2018</li><li><span class="item_label"><b>Published</b> online</span>15 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00873" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00873</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9551%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMontse%2BErra%252C%2BJoan%2BTaltavull%252C%2BFrancisco%2BJavier%2BBernal%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D21%26contentID%3Dacs.jmedchem.8b00873%26title%3DDiscovery%2Bof%2Ba%2BNovel%2BInhaled%2BPI3K%25CE%25B4%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BRespiratory%2BDiseases%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9567%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00873"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2043</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00873" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Montse&quot;,&quot;last_name&quot;:&quot;Erra&quot;},{&quot;first_name&quot;:&quot;Joan&quot;,&quot;last_name&quot;:&quot;Taltavull&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Javier Bernal&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Francisco Caturla&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Carrascal&quot;},{&quot;first_name&quot;:&quot;Lluís&quot;,&quot;last_name&quot;:&quot;Pagès&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Mir&quot;},{&quot;first_name&quot;:&quot;Sònia&quot;,&quot;last_name&quot;:&quot;Espinosa&quot;},{&quot;first_name&quot;:&quot;Jordi&quot;,&quot;last_name&quot;:&quot;Gràcia&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Domínguez&quot;},{&quot;first_name&quot;:&quot;Mar&quot;,&quot;last_name&quot;:&quot;Sabaté&quot;},{&quot;first_name&quot;:&quot;Stéphane&quot;,&quot;last_name&quot;:&quot;Paris&quot;},{&quot;first_name&quot;:&quot;Mónica&quot;,&quot;last_name&quot;:&quot;Maldonado&quot;},{&quot;first_name&quot;:&quot;Begoña&quot;,&quot;last_name&quot;:&quot;Hernández&quot;},{&quot;first_name&quot;:&quot;Mónica&quot;,&quot;last_name&quot;:&quot;Bravo&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Calama&quot;},{&quot;first_name&quot;:&quot;Montserrat&quot;,&quot;last_name&quot;:&quot;Miralpeix&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;D. Lehner&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Calbet&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9551-9567&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00873&quot;},&quot;abstract&quot;:&quot;Oral PI3Kδ inhibitors such as Idelalisib and Duvelisib have shown efficacy as anticancer agents and Idelalisib has been approved for the treatment of three B-cell cancers. However, Idelalisib has a black box warning on its product label regarding the risks of fatal and serious toxicities including hepatic toxicity, severe diarrhea, colitis, pneumonitis, infections, and intestinal perforation. Some of these side effects are mechanism-related and could hinder the development of Idelalisib for less severe conditions. For respiratory diseases, compounds administered by inhalation are delivered directly to the site of action and may improve the therapeutic index of a drug, minimizing undesired side effects. This work describes the discovery and optimization of inhaled PI3Kδ inhibitors intended for the treatment of severe asthma and COPD. Once the potency was in the desired range, efforts were focused on identifying the particular physicochemical properties that could translate into better lung retention. This medi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00873&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00873" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00873&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00873" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00873&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00873" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00873&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00873&amp;href=/doi/10.1021/acs.jmedchem.8b00873" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00873" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00873" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00873%26sid%3Dliteratum%253Aachs%26pmid%3D30351000%26genre%3Darticle%26aulast%3DErra%26date%3D2018%26atitle%3DDiscovery%2Bof%2Ba%2BNovel%2BInhaled%2BPI3K%25CE%25B4%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BRespiratory%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9551%26epage%3D9567%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290965" title="Catalysts">Catalysts</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Oral PI3Kδ inhibitors such as Idelalisib and Duvelisib have shown efficacy as anticancer agents and Idelalisib has been approved for the treatment of three B-cell cancers. However, Idelalisib has a black box warning on its product label regarding the risks of fatal and serious toxicities including hepatic toxicity, severe diarrhea, colitis, pneumonitis, infections, and intestinal perforation. Some of these side effects are mechanism-related and could hinder the development of Idelalisib for less severe conditions. For respiratory diseases, compounds administered by inhalation are delivered directly to the site of action and may improve the therapeutic index of a drug, minimizing undesired side effects. This work describes the discovery and optimization of inhaled PI3Kδ inhibitors intended for the treatment of severe asthma and COPD. Once the potency was in the desired range, efforts were focused on identifying the particular physicochemical properties that could translate into better lung retention. This medicinal chemistry exercise led to the identification of LAS195319 as a candidate for clinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The PI3K (phosphoinositide 3-kinase) family of lipid kinases comprises three classes, PI3K class I, class II, and class III. PI3K class I is the most characterized, being activated by cell surface receptors to produce phosphatidylinositol-3,4,5-trisphosphate (PIP3). PIP3 is a key cellular mediator that activates downstream signaling pathways involved in relevant cellular processes such as growth, proliferation, chemotaxis, metabolism, and survival. PI3K class I is further subdivided into four different isoforms PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, the first two isoforms being ubiquitously expressed and PI3Kδ and PI3Kγ showing a more restricted expression pattern that seems to play a major role in leukocytes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">PI3Kδ is expressed, although not exclusively, in immune cells such as T-cells, B-cells, neutrophils, mast cells, and basophils modulating relevant functions that include cell migration, cytokine production, antibody production, and even steroid resistance.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Such effects in immune cells suggest that selective pharmacological inhibition of PI3Kδ could be a promising approach for treating respiratory diseases such as asthma and COPD (chronic obstructive pulmonary disease).</div><div class="NLM_p">Considering that oral PI3Kδ inhibitors approved as anticancer agents, such as Idelalisib, have reported serious adverse effects including hepatic toxicity, severe diarrhea, colitis, pneumonitis, infections, and intestinal perforation,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> our internal approach was focused on reducing systemic side effects by administering the compounds by the inhaled route. Inhaled drug delivery presents a huge opportunity for the treatment of respiratory diseases, delivering drugs directly to the site of action which may result in a rapid onset of desired effects and with a potential reduction or avoidance of systemic side effects. Thus, despite challenges associated with designing drugs for inhaled delivery,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> this route of administration represents an attractive alternative for the treatment of these diseases compared to conventional routes of administration. In this respect, GlaxoSmithKline and RespiVert have both reported inhaled PI3Kδ and dual PI3Kδ/PI3Kγ inhibitors which have progressed to clinical studies.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">The aim of this work is to provide an overview of physicochemical properties that may lead to improved lung retention times of inhaled compounds with the intention of avoiding compounds with extremely poor solubility. The low solubility approach can initially provide good duration in the lung, but persistence of undissolved material may be irrelevant as these solid particles are unavailable to elicit a pharmacological effect and may provoke an irritant response if such particles remain in the airways.</div><div class="NLM_p last">Herein is presented the medicinal chemistry program that allowed for the optimization of a series of neutral compounds for inhaled administration and led to the discovery of LAS195319 as an inhaled clinical candidate for the treatment of respiratory diseases such as asthma and COPD.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Medicinal Chemistry Strategy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initially the strategy focused on finding compounds with high potency, to support low inhaled dose and high plasma clearance to ensure low systemic exposure. Recently, we reported the identification of a novel oral PI3Kδ inhibitor <b>1</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Similar to IC87114,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> the co-crystal structure of <b>1</b> and PI3Kδ shows that the ligand also adopts a propeller-shaped conformation in which the pyrrolotriazinone moiety is sandwiched into an induced hydrophobic specificity pocket between Trp760 and Met752. Increasing potency by interacting with the affinity pocket has already been described by Shokat et al. at University of California.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This pocket is flanked on the bottom by the side chains of Asp787 and Asp911 and on the top by Tyr813 as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Thus, efforts toward the identification of highly potent PI3Kδ inhibitors were based on introducing functional groups that could interact with the amino acids present in this region and also give rise to additional clearance routes (e.g., glucuronidation of phenols). Before starting the SAR work around the affinity pocket, the methyl group present in the central core of IC87114 was introduced onto the pyrrolotriazinone scaffold of <b>1</b> to give compound <b>2</b>, which led to an increase in both potency and metabolism (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Pyrrolotriazinone Scaffold</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray co-crystal structure of the binding pocket of human PI3Kδ-containing compound <b>1</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U">5M6U</a>). Hydrogen bonds are colored in green dotted lines and the location of the affinity pocket is shown by the blue circle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> outlines the SAR of the affinity pocket and the impact on both PI3Kδ enzymatic potency and in vitro clearance for aminopyrimidine-containing compounds (named series A). Selectivity versus other class I PI3K family isoforms is also shown. The enzymatic potency of each compound on the four class I PI3K recombinant human isoforms was determined by using a biochemical HTRF assay with a compound preincubation time of 30 min. Assays were run at an ATP concentration equal to the respective Km of every isoform and using a sub-nanomolar concentration of the enzyme.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Exploration of the Affinity Pocket (Series A)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">All assay results are reported as the geometric mean of at least two separate runs.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">PI3Kδ, α, β, and γ activities were measured with an ATP concentration fixed to the Km of each isoform by using a HTRF assay, where the PIP3 product formed from PIP2 is detected by displacement of biotin–PIP3 from the complex resulting in a loss of energy transfer (HTRF).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">NADPH-dependent metabolism (%) expressed as disappearance of parent compound after microsomal incubation for 30 min (1 mg/mL protein and 5 μM compound at 37 °C).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">UDPGA-dependent metabolism (%) expressed as disappearance of parent compound after microsomal incubation for 120 min (1 mg/mL protein and 5 μM compound at 37 °C).</p></div></div><div></div></div><div class="NLM_p">It is clear from the data outlined in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> that incorporating a substituted aromatic or heteroaromatic ring in the affinity pocket leads, in general, to high enzymatic potency for PI3Kδ and high selectivity (>100-fold) over the related α and β isoforms. The high enzymatic potency observed could, in part, be due to the presence of heteroatoms in the aromatic ring that may establish new interactions with the amino acids present in this pocket. These amino acids are well conserved between isoforms, so the presence of such interactions alone cannot explain the good selectivity obtained. However, other known propeller-shaped inhibitors which are described to stabilize a conformational change that opens the above-mentioned hydrophobic specificity pocket in the active site have good selectivity, and this process seems to occur more readily in PI3Kδ than in the other isoforms.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, a propeller shape does not always guarantee PI3Kδ specificity (vide infra).</div><div class="NLM_p">In order to increase the systemic clearance of compounds, functional groups which could favor additional routes of metabolism were introduced. Phase II metabolism involves reactions that chemically change either the drug or oxidative metabolites into compounds (conjugates) that are soluble enough to be excreted in urine. For this purpose the OH substituent on the aromatic ring of phenols, well-known to form these conjugates, was introduced onto different positions of the aromatic group which resided in the affinity pocket. Compound <b>14</b>, with the OH in the para position, showed high in vitro glucuronidation but moderate in vitro potency. Docking studies suggested that in this position there was little potential for new interactions, but heteroatoms in the meta position could potentially form hydrogen bonds either with Lys779 at one side of the pocket or with Tyr813 at the opposite side. Indeed, introduction of a hydrogen-bond acceptor atom such as a fluorine (compound <b>15</b>) in this position increased both the affinity for PI3Kδ and also the extent of glucuronidation of the parent compound. Aminopyrimidine <b>16</b> showed potency similar to compound <b>14</b> but much lower in vitro metabolism. Then, a series of compounds was prepared in which the phenol was fixed in the meta position and a hydrogen bond acceptor group was introduced in the other meta position with the intention to interact with both Lys779 and Tyr813. Such compounds (<b>17</b>–<b>19</b>) had excellent affinity for PI3Kδ and high in vitro clearance. Compound <b>20</b> also showed good PI3Kδ potency, probably due to the capacity of the relatively acidic sulfonamide NH group and/or the oxygens of the sulfone to form hydrogen bonds in this pocket. Removing the OH group of compound <b>20</b> gave an equipotent compound <b>21</b>, indicating that double interaction might not be taking place. Other constrained NH derivatives were also studied (compounds <b>22</b> and <b>23</b>) leading to less potent compounds. Finally, introduction of different linkers between the hinge binding motif and the phenol ring was also studied (compounds <b>24</b>–<b>26</b>), the carboxamide analogue <b>26</b> being the most potent.</div><div class="NLM_p">In parallel, another well-known kinase hinge binding motif, the pyrrolopyrimidine (which led to series B), was explored as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. In this case ortho-substituted phenols were tolerated (compounds <b>32</b>–<b>35</b>) although potency was improved by introducing of additional hydrogen-bond acceptor groups in the meta position (compound <b>33</b>–<b>35</b>), as observed in the previous SAR. The para-substituted phenol <b>36</b> was more potent than the corresponding analogue <b>14</b> and this could be explained by docking studies, which showed a potential new interaction with Lys779 not observed with analogue <b>14</b>. Potency could be slightly improved by adding a hydrogen-bond acceptor atom such as fluorine in the meta position (compound <b>37</b>). Docking studies suggested that a new interaction with Asp787 could be gained from this meta position. However, poor selectivity versus PI3Kα was observed for this compound, demonstrating that not all propeller-shaped compounds have good PI3Kδ specificity. One could hypothesize that the double interaction with the affinity pocket could compensate for the energy required to open the above-mentioned specificity pocket in other PI3K-isoforms. This lack of selectivity was also found in compounds <b>38</b> and <b>39</b>, although the latter just fulfilled our selectivity criteria (≥100-fold versus PI3Kδ). Removal of the phenolic OH-group of <b>39</b> gave rise to the equally potent and more selective compound <b>40</b>. In this case, the double interaction with Lys779 and Asp787 is not possible and, although this did not have an impact on PI3K delta affinity, it could explain the higher selectivity observed versus the other isoforms (vide supra). Phenol bioisosteres such as indoles were then studied leading to potent compounds <b>41</b> and <b>42</b>. In addition, compounds containing small heterocycles such us pyrazoles were synthesized giving rise to the highly potent compounds <b>43</b> and <b>44</b>. Finally, addition of various linkers between the hinge binding motif and the phenol ring was studied and led to potent compounds <b>45</b>–<b>47</b> with high in vitro clearance.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration of the Affinity Pocket (II) (Series B)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All assay results are reported as the geometric mean of at least two separate runs.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">PI3Kδ, α, β, and γ activities were measured with an ATP concentration fixed to the Km of each isoform by using a HTRF assay, where the PIP3 product formed from PIP2 is detected by displacement of biotin–PIP3 from the complex resulting in a loss of energy transfer (HTRF).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">NADPH-dependent metabolism (%) expressed as disappearance of parent compound after microsomal incubation for 30 min (1 mg/mL protein and 5 μM compound at 37 °C).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">UDPGA-dependent metabolism (%) expressed as disappearance of parent compound after microsomal incubation for 120 min (1 mg/mL protein and 5 μM compound at 37 °C).</p></div></div><div></div></div><div class="NLM_p">The X-ray co-crystal structure of <b>39</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) bound to PI3Kδ was resolved at 2.72 Å, revealing a number of polar interactions in the affinity pocket as was predicted. The OH of the phenol group forms hydrogen bonds with the side chain atoms of Asp787 and Tyr813, while one of the oxygens of the sulfone forms a hydrogen bond with the side chain of Lys779. In addition, the pyrrolopyrimidine forms hydrogen bonds to the hinge region with the main chain atoms of Glu826 and Val828. Similar to the co-crystal structure obtained with compound <b>1</b>, the molecule adopts a propeller-shaped conformation where the pyrrolotriazinone moiety is sandwiched into the induced hydrophobic specificity pocket between Trp760 and Met752.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray co-crystal structure of the binding pocket of human PI3Kδ-containing compound <b>39</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W">6G6W</a>). Hydrogen bonds are colored in green dotted lines and distances are shown in blue (Å).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since many compounds with good in vitro profiles were found in these initial studies, before embarking on further SAR work around the affinity pocket, an in vivo pharmacokinetic assay was used to identify molecules with the highest lung retention. Briefly, five compounds were pooled and administered in solution to rats via the intratracheal route using cassette dosing. Each compound was administered at a dose of 0.015 mg/kg, a low enough dose to minimize any potential solubility issue which could have an impact on the lung retention profile of the compounds assayed (the thermodynamic solubility of some compounds tested in water at pH = 7.4 was <0.01 μg/mL) . A total of 64 compounds (20 from series A and 44 from series B) were tested in this assay, and the lung and plasma profiles of the compounds were evaluated. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> shows the correlation between the amount of compound recovered in the lung (expressed as percent of dose) at the first kinetic time point after administration versus the overall exposure (AUC) in the lung. From this plot we can conclude that good initial lung recovery does not always translate into good lung retention, but what seems clear is that compounds that show poor initial lung recovery never translate into compounds with good lung retention.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of the relationship between dose-normalized lung exposure (AUC/dose) and the amount of compound recovered in the lung (expressed as percentage of dose) at the first kinetic time point after administration. The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Purple line corresponds with a dose-normalized lung exposure of 100 μg·h/g and the blue line corresponds with the amount of compound recovered in the lung (expressed as percent of dose) of 50% at the first kinetic time point after administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The lung and plasma concentrations at different kinetic time points were studied for each compound, and a ratio between both was then calculated. For compounds intended to be administered via the inhaled route, the plasma concentrations and overall systemic exposure should be minimized as much as possible in order to avoid potential systemic side effects. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows the correlation between the lung/plasma ratio at equilibrium (1 h after administration) versus the dose-normalized lung exposure (AUC/dose) for each compound. In this case a good correlation is observed between both parameters, allowing the selection of compounds with good overall lung exposure and an optimal lung/plasma split. Many compounds showed lung/plasma ratios of over a 100-fold, and a few even showed ratios of over 1000-fold.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of the dose-normalized lung exposure (AUC/dose) for each compound versus the lung/plasma ratio at equilibrium (1 h after administration). The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Blue lines correspond with lung/plasma ratios of 100 and 1000 at 1 h after compound administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To better understand the physicochemical properties that could influence lung retention, several parameters were plotted against each other in order to study possible correlations.</div><div class="NLM_p">First of all, permeability was studied and compared with dose-normalized lung exposure as previously described. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, compounds with limited permeability, PAMPA < 1, show, in general, better lung retention than those with higher permeability.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plot of the relationship between PAMPA (expressed as 10<sup>–6</sup> cm/s) and dose-normalized lung exposure (AUC/dose) for each compound. The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Blue line corresponds with a dose-normalized lung exposure of 50 μg·h/g and the purple line corresponds with a PAMPA of 1 × 10<sup>–6</sup> cm/s.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other physical properties such as hydrogen bond donor counts and polar surface area have been described to be positively correlated with lung retention.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Thus, when tPSA was plotted versus MW (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), it was observed that compounds with higher lung exposure (represented by the bigger circles) were the ones with MW above 550 and with a tPSA higher than 150. However, as polar surface area tends to increase with molecular weight, it is difficult to find examples in the top left and bottom right quadrants and one cannot discard that only one and not both parameters are required for higher lung retention times. An increase in the number of H-bond donors also positively impacted on lung exposure as shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. However, it should be taken into account that increasing the number of H-bond donors is likely to compromise the cellular permeability of compounds for an intracellular target. To this end, the ratio between cellular and enzymatic potency was calculated for all compounds and a higher proportion of compounds with ratios > 10 was found for those having five H-bond donors (data not shown). Therefore, examples with six H-bond donors were not synthesized.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Relationship between theoretical polar surface area (TPSA) and molecular weight (MW) versus lung exposure. The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Blue lines correspond with a molecular weight of 550 Da and a theoretical polar surface area of 150.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Plot of the relationship between the number of hydrogen-bond donors (HBDs) versus dose-normalized lung exposure (AUC/Dose). The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Dose-normalized lung exposure is represented in the <i>y</i>-axis and the number of hydrogen-bond donors in the <i>x</i>-axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The time course graphs of compound recovery from lung tissue after i.t. administration of a set of compounds from both series at 0.015 mg/kg in solution were superimposed and colored by the number of H-bond donors present in each molecule (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The visual data suggest that increasing the number of H-bond donors leads to a positive impact on the distribution phase, resulting in a higher lung AUC.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Time course of compound recovery from lung tissue after i.t. administration of different compounds at 0.015 mg/kg in solution. The figure was produced using GraphPad Prism 7. Colors indicate the number of hydrogen-bonds donors present in each compound (blue for 3 HBD, red for 4 HBD, and green for 5HBD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With this information it can be concluded that, for this series of nonbasic compounds, the physicochemical properties (and the respective optimal values) contributing to higher lung retention are PAMPA < 1, MW > 550, PSA > 150, and H-bond donors >3. For this reason, chemical efforts for subsequent compounds were focused on the synthesis of molecules fulfilling the aforementioned parameters.</div><div class="NLM_p">Following this strategy compound <b>50</b> was identified and compared with compound <b>15</b>, an equipotent inhibitor. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, only compound <b>50</b> fulfills the criteria previously described in terms of permeability and physicochemical properties. Such differences should translate into better lung retention for compound <b>50</b> compared to compound <b>15</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Profiles of Compounds <b>15</b> and <b>50</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0019.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" align="center" char="."><i>P</i><sub>app</sub> (×10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">enzymatic HTRF<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> PI3Kδ/α/β/γ</th><th class="colsep0 rowsep0" align="center" char=".">M-CSF p-Akt<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">PAMPA</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">tPSA</th><th class="colsep0 rowsep0" align="center">HBD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">0.5/1100/87/11</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="left">471</td><td class="colsep0 rowsep0" align="left">119</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">0.5/1900/10/36</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">594</td><td class="colsep0 rowsep0" align="left">169</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">All assay results are reported as the geometric mean of at least two separate runs.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">PI3Kδ, α, β, and γ activities were measured with an ATP concentration fixed to the Km of each isoform by using a HTRF assay, where the PIP3 product formed from PIP2 is detected by displacement of biotin–PIP3 from the complex resulting in a loss of energy transfer (HTRF).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">THP-1 cells were treated with compounds for 30 min, stimulated with M-CSF at EC<sub>80</sub> for 3 min and then lysed to measure (by ELISA) pAkt (Thr308) produced through PI3Kδ.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Permeability values at RT in PBS (containing 2% DMSO); compound concentration in donor compartment, 20 μM.</p></div></div></div><div class="NLM_p">Thus, both compounds were further profiled in rat in vivo PK experiments. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, both compounds showed high clearance and high volumes of distribution, resulting in short terminal half-lives and poor oral bioavailability. These compounds were then administered via the intratracheal route both in solution and in suspension (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). As predicted, compound <b>50</b> showed a much higher lung exposure compared to compound <b>15</b> in solution as well as in suspension. In addition, a much higher lung/plasma partition ratio was obtained with compound <b>50</b>, reinforcing our goal of reducing on-target systemic side effects. Lung half-lives were slightly increased after administration of the compounds in suspension as compared to in solution, probably due to the dissolution rate of these poorly soluble compounds (thermodynamic aqueous solubility of 36 μg/mL for compound <b>15</b> and 3 μg/mL for compound <b>50</b>). Compound <b>50</b> also showed an improved lung profile versus other closely related compounds <b>41</b> and <b>42</b> (data not shown)—neither of these examples fulfilled the above-defined criteria.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rat PK Profiles of Compound <b>15</b> in Comparison with <b>50</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>l</sub> (mL/(min/kg))<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PPB (% bound)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">149</td><td class="colsep0 rowsep0" align="left">236</td><td class="colsep0 rowsep0" align="left">112</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="char" char=".">94.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">171</td><td class="colsep0 rowsep0" align="left">455</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">98.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Mean values (<i>n</i> = 2) in Wistar rat after an administration of 1 mg/kg i.v.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Mean values (<i>n</i> = 2) in Wistar rat after an administration of 1 mg/kg p.o.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Mean rat PPB values determined by equilibrium dialysis at a plasma concentration of 1 μM at 37 °C.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Rat i.t. PK Profiles of Compound <b>15</b> in Comparison with <b>50</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">AUC<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd dose route (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">lung (μg·h/g)</th><th class="colsep0 rowsep0" align="center" char=".">plasma (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">lung/plasma ratio</th><th class="colsep0 rowsep0" align="center" char=".">lung (μg/g)</th><th class="colsep0 rowsep0" align="center" char=".">plasma (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">lung (h)</th><th class="colsep0 rowsep0" align="center" char=".">plasma (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">15 0.015 (i.t., solution)</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">36.3</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">50 0.015 (i.t., solution)</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">2925</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">15 0.3 (i.t., susp.)</td><td class="colsep0 rowsep0" align="char" char=".">30.6</td><td class="colsep0 rowsep0" align="char" char=".">147.6</td><td class="colsep0 rowsep0" align="char" char=".">207</td><td class="colsep0 rowsep0" align="char" char=".">18.6</td><td class="colsep0 rowsep0" align="char" char=".">2000.7</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">50 0.3 (i.t., susp.)</td><td class="colsep0 rowsep0" align="char" char=".">459.6</td><td class="colsep0 rowsep0" align="char" char=".">96.5</td><td class="colsep0 rowsep0" align="char" char=".">4763</td><td class="colsep0 rowsep0" align="char" char=".">73.3</td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Mean values (<i>n</i> = 2) in Wistar rat after an administration of 0.015 mg/kg i.t. in solution or after an administration of 0.3 mg/kg i.t. in suspension.</p></div></div></div><div class="NLM_p">Considering the difference in terms of lung retention, a better in vivo efficacy was expected for compound <b>50</b> compared to compound <b>15</b>. The OVA-induced inflammation model in the brown Norway rat was selected to assess the in vivo efficacy of both compounds. In this model, an OVA challenge in sensitized rats causes an allergic inflammatory response that provokes an influx of inflammatory cells to the animal airways and induces functional lung changes that mimic certain features of human asthma. Intratracheal administration of compound <b>50</b> (LAS195319) as a suspension at 0.3 and 0.1 mg/kg i.t. One hour before OVA aerosol challenge caused an inhibition of eosinophil and neutrophil infiltration in BAL fluid of 55% and 77%, respectively, at the higher dose (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) and 21% and 42% at the lower dose. Fluticasone at 0.3 mg/kg used as positive control, causing inhibition of neutrophil and eosinophil infiltration of 89% and 82%, respectively. Results obtained with compound <b>15</b> demonstrated that it was required to increase the dose in order to see efficacy, showing no effect in eosinophil infiltration and a modest inhibition of neutrophil infiltration in BAL fluid of 37% when administered at 1 mg/kg. (data not shown).</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Inhibition of inflammatory cell infiltration in the OVA rat model after i.t. administration of LAS195319. Inhibition of inflammatory cell infiltration was studied measuring neutrophils (A) and eosinophils (B) in BALF induced by OVA challenge in a Brown Norway rat model after i.t. administration of LAS195319. Two independent experiments were performed (<i>n</i> = 11–16 per dose). One way ANOVA and Dunnett’s test with *, ***, **** indicating <i>P</i> < 0.05, 0,001, and 0,0001 versus vehicle + OVA group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At the efficacious dose of 0.3 mg/kg for LAS195319, the maximum free drug concentration in plasma (free <i>C</i><sub>max</sub>) after i.t. administration was 0.3 nM, not covering the cellular IC<sub>50</sub> determined for this compound and thus, minimizing the potential for side effects associated with systemic drug exposure.</div><div class="NLM_p">As a consequence of these encouraging results, LAS195319 was further characterized. Enzymatically, the compound showed higher selectivity versus PI3Kα than for PI3Kβ and PI3Kγ (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The IC<sub>50</sub> for cellular inhibition of PI3Kδ  using THP-1 cells stimulated with M-CSF was measured at 2.7 nM for this compound (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). To evaluate the cellular inhibition of PI3Kβ, an assay based on stimulation of HUVEC cells with sphingosine-1-P was employed.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The results, 61% inhibition at 10 μM, indicated that the poor enzymatic selectivity between δ and β isoforms (20-fold) was not translated to the cellular level. In addition, LAS195319 was highly selective against an extensive panel of protein and lipid kinases and GPCRs (see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_002.pdf" class="ext-link">Supporting Information</a>). In terms of cardiac safety, LAS195319 did not show any activity on the hERG channel up to a concentration of 10 μM. Finally, LAS195319 confirmed very low oral bioavailability in a second preclinical species such as dog (<i>F</i> < 1%) as was desired to avoid the systemic side effects that have been described for oral PI3Kδ inhibitors.</div><div class="NLM_p last">Taken together, these properties made LAS195319 an ideal inhaled candidate for clinical development for the treatment of respiratory diseases. A full biological profile will be published in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the key intermediate <b>9</b> started from the pyrrole carboxylic acid <b>3</b>, which was transformed into the amide <b>4</b> by formation of the acyl chloride and subsequent reaction with aniline (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). <i>N</i>-Amination of the pyrrole <b>4</b> was achieved by a biphasic reaction with chloramine generated in situ from the oxidation of ammonia with sodium hypochlorite using <i>N</i>-methyl-<i>N</i>,<i>N</i>-dioctyloctan-1-aminium chloride as phase-transfer catalyst. Under these conditions the amination occurs selectively on the NH of the pyrrole, giving <b>5</b> as the sole regioisomer. Condensation of <b>5</b> with Boc-protected alanine mediated by propylphosphonic anhydride gave amide <b>6</b>. The cyclization of <b>6</b> to the corresponding pyrrolotriazine <b>8</b> involved a two-step process.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In the first step, treatment of <b>6</b> with the complex formed from triphenylphosphine and bromine in methylene chloride gave the O-cyclized intermediate <b>7</b>, which, without isolation, was rearranged to the more stable pyrrolotriazine <b>8</b> by treatment with a 7 M solution of ammonia in methanol. Finally, deprotection of the Boc group with trifluoroacetic acid gave amine <b>9</b>.</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Amino Intermediate <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) oxalyl chloride, DCM; (b) aniline, DIPEA, DCM; (c) NaClO, NaOH, NH<sub>4</sub>OH, NH<sub>4</sub>Cl, water/MTBE, <i>N</i>-methyl-<i>N</i>,<i>N</i>-dioctyloctan-1-aminium chloride; (d) <i>N</i>-Boc-Ala, 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (PPACA), DIEA, EtOAc; (e) PPh<sub>3</sub>, Br<sub>2</sub>, TEA, DCM; (f) NH<sub>3</sub>/MeOH; (g) TFA, DCM.</p></p></figure><div class="NLM_p">Aminopyrimidine-containing compounds <b>14</b>–<b>26</b> were prepared according to the synthetic route described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Nucleophilic attack of amine <b>9</b> on chloropyrimidines <b>10</b> in the presence of cesium fluoride gave compounds of type <b>12</b>. Reaction of compounds <b>12</b> (either X = Br or the more reactive X = I) with the corresponding boronic acids or boronic esters under Suzuki reaction conditions yielded final compounds <b>14</b>–<b>24</b>. Alternatively, thioether <b>25</b> was obtained by a copper-catalyzed arylation of the corresponding aromatic thiol with intermediate <b>12</b>.</div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to Compounds <b>14</b>–<b>26</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CsF, DIEA, tBuOH; (b) Ar–B(OH)<sub>2</sub> or Ar-Bpin, PdCl<sub>2</sub>dppf·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane; (c) Ar–CH<sub>2</sub>–Bpin, PdCl<sub>2</sub>dppf·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane; (d) Ar-SH, CuI, K<sub>2</sub>CO<sub>3</sub>, DCM; (e) DIEA, EtOH; (f) LiOH, THF/EtOH/water; (g) ArNH<sub>2</sub>, HATU, DIEA, DMF; (h) TFA.</p></p></figure><div class="NLM_p">The preparation of compound <b>26</b> started with the nucleophilic attack of amine <b>9</b> on the protected chloropyrimidine ester <b>11</b>. In this case, milder conditions to those described above were used—refluxing ethanol in the presence of DIEA was sufficient to complete the reaction. Subsequent hydrolysis of the ester with lithium hydroxide gave carboxylic acid <b>13</b>, which was reacted with an aniline under standard HATU-mediated coupling conditions to give the corresponding amide and, after a final deprotection of the <i>p</i>-methoxybenzyl group with trifluoroacetic acid, compound <b>26</b> was isolated.</div><div class="NLM_p">For the preparation of the compounds with the pyrrolopyrimidine hinge binder <b>32</b>–<b>47</b>, an analogous synthetic route was followed (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Compounds <b>32</b>–<b>47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CsF, DIEA, tBuOH; (b) Ar–B(OH)<sub>2</sub> or Ar-Bpin, PdCl<sub>2</sub>dppf·DCM or PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> or Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME/water or DMF; (c) 1. TFA or BBr<sub>3</sub>/DCM 2. NH<sub>3</sub>/MeOH; (d) DIEA, <i>t</i>BuOH; (e) H<sub>2</sub>, 10% Pd/C, MeOH; (f) ArNH<sub>2</sub>, PPACA, DIEA, EtOAc.</p></p></figure><div class="NLM_p">Nucleophilic attack of amine <b>9</b> on chloropyrrolopyrimidine <b>27</b> in the presence of cesium fluoride gave intermediate <b>28</b>. Reaction of bromo derivative <b>28</b> with the corresponding boronic acids or boronic esters under Suzuki reaction conditions and followed by SEM deprotection yielded compounds <b>32</b>–<b>45</b>. The copper-catalyzed reaction of <b>28</b> with an aromatic thiol failed but the desired target <b>46</b> was finally able to be prepared by nucleophilic substitution of amine <b>9</b> with the prefunctionalized chloropyrrolopyrimidine <b>29</b>, followed by SEM deprotection. This deprotection took place in two steps as mainly the corresponding hemiaminal intermediates were obtained after subjecting the SEM-protected compounds to acidic conditions—subsequent treatment with ammonia was required to yield the final compounds.</div><div class="NLM_p">The nucleophilic substitution reaction of amine <b>9</b> with the unprotected chloropyrrolopyrimidine ester <b>30</b> was conducted in <i>t</i>BuOH. Due to the enhanced reactivity of <b>30</b>, the addition of cesium fluoride was not needed in this case for the reaction to reach completion. Subsequent removal of the benzyl group by Pd-catalyzed hydrogenation gave carboxylic acid <b>31</b>, which was reacted with the corresponding aniline after propylphosphonic anhydride activation to yield amide <b>47</b>.</div><div class="NLM_p">Although LAS195319 was first synthesized by the route described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, during the course of the Suzuki reaction partial hydrolysis of the sulfamide was observed. Thus, a multigram synthesis of this compound was achieved following an alternative synthetic route as described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Bromo derivative <b>28</b> was reacted under Suzuki conditions with boronate <b>48</b> to give the free indolamine intermediate <b>49</b>. The sulfamide was then formed by treatment of <b>49</b> with sulfamoyl chloride in the presence of pyridine in THF. Finally, deprotection of the SEM group furnished LAS195319 in an overall improved yield.</div><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to LAS195319<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) PdCl<sub>2</sub>dppf·DCM, Na<sub>2</sub>CO<sub>3</sub>, DME/water; (b) ClSO<sub>2</sub>NH<sub>2</sub>, pyridine, THF; (c) (1) TFA, (2) NH<sub>3</sub>/MeOH.</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein is described the medicinal chemistry exercise that resulted in the discovery of LAS195319, a potent PI3Kδ inhibitor with pharmacokinetic properties suitable for inhaled administration. During this exercise, the key physicochemical properties that were relevant for lung retention of this particular series of nonbasic compounds were identified and used in lead optimization.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Method</h3><div class="NLM_p">Reagents, starting materials, and solvents were purchased from commercial suppliers and used as received. Concentration or evaporation refers to evaporation under vacuum using a Büchi rotary evaporator.</div><div class="NLM_p">Reaction products were purified, when necessary, by flash chromatography using Biotage SP1 or Isolera automated purification systems using the gradient specified for each compound. Purifications using reverse phase chromatography were also performed using a Biotage SP1 or Isolera automated purification system equipped with a C18 column and using a gradient of water/acetonitrile/MeOH (1:1) (0.1% (v/v) ammonium formate both phases) from 0% to 100% acetonitrile/MeOH (1:1) in 40 column volumes. The conditions “formic acid buffer” refer to the use of 0.1% (v/v) formic acid in both phases. The appropriate fractions were collected and the solvents evaporated under reduced pressure and/or lyophilized.</div><div class="NLM_p">The purity of synthesized compounds was determined by LC-MS analysis, and all compounds for biological testing were ≥95% pure. UPLC chromatographic separations were obtained using a Waters Acquity UPLC system coupled to a SQD mass spectrometer detector. The system was equipped with an Acquity UPLC BEH C-18 (2.1 mm × 50 mm, 1.7 μm) column. The mobile phase (B) consisted of a mixture of formic acid (0.4 mL), ammonia (0.1 mL), methanol (500 mL), and acetonitrile (500 mL) while mobile phase (A) consisted of a mixture of formic acid (0.5 mL), ammonia (0.125 mL), and water (1000 mL). A gradient of 5–95% of B in A was used for separations. The run time was 5 min, and injection volume was 0.5 μL. Chromatograms were processed using diode array. Mass spectra (<i>m</i>/<i>z</i>) of the chromatograms were acquired using positive and negative electrospray ionization.</div><div class="NLM_p">HRMS was performed for the most advanced compounds using a Agilent 6220 accurate-mass time of flight LC/MS system.</div><div class="NLM_p"><sup>1</sup>H nuclear magnetic resonance spectra were recorded on a Varian Mercury plus operating at a frequency of 400 MHz. Samples were dissolved in the specified deuterated solvent, and tetramethylsilane was used as reference. Chemical shifts (δ) are given in part per million to 2 decimal places. Coupling constants (<i>J</i> values) are given in parts per million to 1 decimal place. The following abbreviations are used: singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), double doublet (dd), double triplet (dt), triple doublet (td), multiplet (m), broad signal (br. s), and apparent (app). Partial refers to spectra where a peak or peaks are obscured under solvent peaks and cannot be assigned. Signals of protons attached to heteroatoms may or may not be present according to solvent conditions.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-Methyl-<i>N</i>-phenyl-1<i>H</i>-pyrrole-2-carboxamide (<b>4</b>)</h4><div class="NLM_p last">3-Methyl-1<i>H</i>-pyrrole-2-carboxylic acid <b>3</b> (6.97 g, 0.06 mol) was dissolved in 150 mL of DCM and 1 mL of DMF. Oxalyl chloride (7.26 mL, 0.08 mol) dissolved in 50 mL of DCM was added dropwise over 60 min, and the mixture was stirred at room temperature (r.t.) for 2 h. The mixture was concentrated to dryness and was redissolved in 150 mL of DCM. A solution of aniline (5.71 g, 0.06 mol) and DIEA (14.5 mL, 0.08 mol) dissolved in 50 mL of DCM was added dropwise, and the reaction was stirred at room temperature for 2 h. The mixture was washed sequentially with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The residue was purified by flash chromatography (0–40% hexane–EtOAc) to give 6.66 g (60% yield) of <b>4</b> as a brown solid. LRMS <i>m</i>/<i>z</i> 201 [M + 1]<sup>+</sup>.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-Amino-3-methyl-<i>N</i>-phenyl-1<i>H</i>-pyrrole-2-carboxamide (<b>5</b>)</h4><div class="NLM_p last">A three-necked flask was charged with a 32% aqueous solution of NaOH (95 mL, 665 mmol), an 8 M aqueous solution of NH<sub>4</sub>OH (31 mL, 250 mmol), NH<sub>4</sub>Cl (10.7 g, 200 mmol) and Aliquat 336 (1.34 g, 3.30 mmol). Then, a solution of <b>4</b> (6.6 g, 33.20 mmol) in 140 mL of Et<sub>2</sub>O and 70 mL of MTBE was added, and the resulting mixture was cooled to 0 °C to give a suspension. A 10% aqueous solution of NaClO (224 mL, 300 mmol) was added dropwise over 60 min with vigorous stirring, and the reaction mixture was stirred at r.t. overnight. The reaction mixture was then diluted with AcOEt until no suspended material was observed. The layers were separated, and the organic phase was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give 7.54 g (90% yield) of <b>5</b>, which was used in the next step without any further purification. LRMS <i>m</i>/<i>z</i> 216 [M + 1]<sup>+</sup>.</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl (<i>S</i>)-(1-((3-methyl-2-(phenylcarbamoyl)-1<i>H</i>-pyrrol-1-yl)amino)-1-oxopropan-2-yl)carbamate (<b>6</b>)</h4><div class="NLM_p last">Compound <b>5</b> (5.30 g, 24.60 mmol) was dissolved in 35 mL of AcOEt and (<i>S</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)propanoic acid (6.50 g, 34.40 mmol) was added. The mixture was cooled in an ice bath, and DIEA (19.8 mL, 113.7 mmol) was added dropwise. After 15 min stirring at 0 °C, T3P (50% in ethyl acetate, 14.3 mL, 48.00 mmol) was added dropwise, and the reaction was stirred at r.t. for 3 h. Further (<i>S</i>)-2-((tert-butoxycarbonyl)amino)propanoic acid (3.25 g, 17.2 mmol), DIEA (20 mL, 114 mmol), and T3P (14.3 mL, 48.04 mmol) were added dropwise at 0 °C, and the reaction was stirred at r.t. overnight. The reaction mixture was poured into water and extracted with AcOEt. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>,sulf, and concentrated under reduced pressure. The crude product was purified by flash chromatography (0–60% hexane–EtOAc) to obtain 7.15 g (75% yield) of <b>6</b> as a solid. LRMS <i>m</i>/<i>z</i> 387 [M + 1]<sup>+</sup>.</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (<i>S</i>)-(1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)carbamate (<b>8</b>)</h4><div class="NLM_p last">PPh<sub>3</sub> (6.8 g, 25.93 mmol) was dissolved in 50 mL of DCM. Br<sub>2</sub> (1.33 mL, 25.97 mmol) was added dropwise, and the reaction was stirred at r.t. for 30 min. A suspension of <b>6</b> (7.15 g, 18.5 mmol) and triethylamine (10.3 mL, 73.90 mmol) in 100 mL of DCM was added, and the reaction mixture was stirred at 60 °C for 2 h. The mixture was concentrated to dryness and was redissolved in a pressure reactor with a 7 M solution of NH<sub>3</sub> in MeOH (350 mL, 2415 mmol). The mixture was heated at 100 °C for 32 h, then cooled to room temperature, and evaporated under reduced pressure. The residue was partitioned between EtOAc and water, and the organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>,sulf, and concentrated. The crude product was purified by flash chromatography (0–50% hexane–EtOAc) to obtain 0.95 g (14% yield) of <b>8</b> as a yellow solid. LRMS <i>m</i>/<i>z</i> 369 [M + 1]<sup>+</sup>.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i>)-2-(1-Aminoethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>9</b>)</h4><div class="NLM_p last">Compound <b>8</b> (950 mg, 2.58 mmol) was dissolved in 5 mL of DCM, and TFA (993 μL, 12.90 mmol) was added. The mixture was stirred at r.t. overnight. The reaction mixture was evaporated to dryness and was partitioned between EtOAc and a saturated aqueous solution of KHCO<sub>3</sub>. The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>,sulf, and concentrated under reduced pressure to give 0.55 g (78% yield) of <b>9</b>. LRMS <i>m</i>/<i>z</i> 269 [M + 1]<sup>+</sup>.</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-2-(1-((6-Amino-5-iodopyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>12b</b>)</h4><div class="NLM_p last">Compound <b>9</b> (460 mg, 1.81 mmol), 6-chloro-5-iodopyrimidin-4-amine (924 mg, 3.62 mmol), and CsF (550 mg, 3.62 mmol) were suspended in 10 mL of <i>t</i>BuOH. DIEA (1.58 mL, 9.07 mmol) was added, and the mixture was stirred at 140 °C in a sealed vessel for 40 h. The reaction mixture was partitioned between water and EtOAc, and the organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and filtered and the solvents were removed. The product was purified by reverse phase chromatography to furnish 481 mg (56% yield) of <b>12b</b>. LRMS <i>m</i>/<i>z</i> 474 [M + 1]<sup>+</sup></div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-4-((4-Methoxybenzyl)amino)-6-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)pyrimidine-5-carboxylic acid (<b>13</b>)</h4><div class="NLM_p last">Compound <b>9</b> (167 mg, 0.62 mmol) in EtOH (3 mL) was treated with ethyl 4-chloro-6-((4-methoxybenzyl)amino)pyrimidine-5-carboxylate (200 mg, 0.62 mmol) and DIEA (220 μL, 1.26 mmol), and the mixture was heated to reflux and stirred overnight. The mixture was allowed to cool to r.t., and the white solid that formed was filtered and washed with Et<sub>2</sub>O. The solid was dissolved in 2 mL of EtOH and 3 mL of THF, and a solution of LiOH (213 mg, 50.80 mmol) in water was added and the mixture was heated at 50 °C overnight. Further, LiOH (213 mg, 50.80 mmol) in 3 mL of water was added and the reaction mixture heated at 50 °C for an additional 4 h. The reaction mixture was diluted with water and acidified to pH 5 with 5 M HCl. The aqueous phase was extracted with EtOAc, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give 300 mg (99% yield) of <b>13</b> as a white solid. LRMS <i>m</i>/<i>z</i> 526 [M + 1]<sup>+</sup>.</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Typical Procedure for the Reaction of Intermediates <b>12a</b>,<b>b</b> and <b>28</b> with Boronic Acids or Boronic Esters</h4><div class="NLM_p last">Exemplified for (<i>S</i>)-2-(1-((6-amino-5-(4-hydroxyphenyl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>14</b>). To a solution of <b>12b</b> (50 mg, 0.10 mmol) in dioxane (5 mL), 21 mg (0.15 mmol) of (4-hydroxyphenyl)boronic acid, 14 mg (0.02 mmol) of PdCl<sub>2</sub>(dppf)<sub>2</sub>·DCM and 231 μL (0.46 mmol) of a 2 M aqueous solution of Na<sub>2</sub>CO<sub>3</sub> were added. The mixture was stirred under argon atmosphere at 80 °C for 18 h and then diluted with EtOAc. The resulting solution was washed with water and brine, dried over MgSO<sub>4</sub>, and filtered, and the solvents were removed under reduced pressure. The crude product was purified by flash chromatography to give 5 mg (11% yield) of <b>14</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.59–7.42 (m, 4H), 7.28 (d, <i>J</i> = 7.0 Hz, 1H), 7.13 (d, <i>J</i> = 2.6 Hz, 2H), 7.01 (s, 2H), 6.31 (d, <i>J</i> = 2.2 Hz, 1H), 5.10–4.72 (m, 3H), 2.66 (d, <i>J</i> = 22.3 Hz, 3H), 2.49 (d, <i>J</i> = 6.7 Hz, 3H), 1.24 (d, <i>J</i> = 6.4 Hz, 3H). LRMS <i>m</i>/<i>z</i> 454 [M + 1]<sup>+</sup>, retention time (rt) = 2.08 min.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of Compounds <b>15</b>–<b>24</b></h3><div class="NLM_p">The following compounds were prepared according to the procedure described for compound <b>14</b>.</div><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-2-(1-((6-Amino-5-(3-fluoro-4-hydroxyphenyl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>15</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12b</b> and (3-fluoro-4-hydroxyphenyl)boronic acid in 9% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (s, 1H), 7.64–7.42 (m, 4H), 7.29 (d, <i>J</i> = 7.2 Hz, 1H), 7.08 (d, <i>J</i> = 67.0 Hz, 3H), 6.32 (d, <i>J</i> = 2.3 Hz, 1H), 4.99 (s, 1H), 4.91 (s, 1H), 4.72 (s, 2H), 2.49 (s, 3H), 1.67 (s, 2H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). LRMS <i>m</i>/<i>z</i> 472 [M + 1]<sup>+</sup>, rt = 2.04 min. HRMS (ES<sup>+</sup>) for C<sub>25</sub>H<sub>23</sub>FN<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> calculated 472.1892, found 472.1891.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-2-(1-((2′,6-Diamino[5,5′-bipyrimidin]-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12b</b> and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine in 28% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (s, 2H), 8.09 (s, 1H), 7.63–7.43 (m, 4H), 7.29 (d, <i>J</i> = 7.3 Hz, 1H), 7.15 (d, <i>J</i> = 2.4 Hz, 1H), 6.30 (s, 1H), 5.39 (d, <i>J</i> = 23.1 Hz, 2H), 5.12–4.80 (m, 2H), 4.63 (d, <i>J</i> = 22.9 Hz, 2H), 2.48 (s, 3H), 1.25 (d, <i>J</i> = 6.7 Hz, 3H). LRMS <i>m</i>/<i>z</i> 455 [M + 1]<sup>+</sup>, rt = 1.76 min.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-2-(1-((6-Amino-5-(3-fluoro-5-hydroxyphenyl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12b</b> and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine in 35% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8,45 (s, 1H), 8.04 (s, 1H), 7.59–7.42 (m, 3H), 7.28 (d, <i>J</i> = 7.0 Hz, 1H), 7.13 (d, <i>J</i> = 2.6 Hz, 2H), 7.01 (s, 2H), 6.31 (d, <i>J</i> = 2.2 Hz, 1H), 5.10–4.72 (m, 3H), 2.66 (d, <i>J</i> = 22.3 Hz, 2H), 2.49 (d, <i>J</i> = 6.7 Hz, 3H), 1.24 (d, <i>J</i> = 6.4 Hz, 3H). LRMS <i>m</i>/<i>z</i> 472 [M + 1]<sup>+</sup>, rt = 2.31 min.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-2-(1-((6-Amino-5-(3-chloro-5-hydroxyphenyl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12a</b> and (3-chloro-5-hydroxyphenyl)boronic acid in 32% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.07 (s, 1H), 7.78 (s, 1H), 7.55–7.31 (m, 6H), 6.81 (d, J = 2.0 Hz, 1H), 6.63 (s, 2H), 6.40 (d, J = 2.4 Hz, 1H), 5.63 (d, J = 7.8 Hz, 3H), 4.91–4.68 (m, 1H), 2.35 (d, J = 15.2 Hz, 3H), 1.21 (d, J = 6.7 Hz, 3H. LRMS <i>m</i>/<i>z</i> 488 [M + 1]<sup>+</sup>, rt = 2.54 min.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-2-(1-((6-Amino-5-(3-hydroxy-5-(trifluoromethyl)phenyl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12a</b> and (3-hydroxy-5-(trifluoromethyl)phenyl)boronic acid in 25% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (s, 1H), 7.80 (s, 1H), 7.57–7.32 (m, 6H), 6.96 (d, <i>J</i> = 58.4 Hz, 3H), 6.40 (d, <i>J</i> = 2.5 Hz, 1H), 5.78–5.55 (m, 3H), 4.88–4.69 (m, 1H), 2.36 (s, 3H), 1.20 (d, <i>J</i> = 6.7 Hz, 3H). LRMS <i>m</i>/<i>z</i> 522 [M + 1]<sup>+</sup>, rt = 2.68 min.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-(3-(4-Amino-6-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)pyrimidin-5-yl)-5-hydroxyphenyl)methanesulfonamide (<b>20</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12a</b> and <i>N</i>-(3-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide in 32% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.73 (s, 1H), 8.34 (s, 1H), 7.80 (d, <i>J</i> = 7.1 Hz, 1H), 7.65–7.26 (m, 6H), 6.74–6.64 (m, 1H), 6.48 (d, <i>J</i> = 17.6 Hz, 1H), 6.39 (dd, <i>J</i> = 2.6, 0.6 Hz, 1H), 6.30 (s, 1H), 5.53 (d, <i>J</i> = 20.9 Hz, 3H), 4.74 (s, 1H), 3.00 (s, 3H), 2.37 (d, <i>J</i> = 5.1 Hz, 3H), 1.26–1.09 (m, 3H). LRMS <i>m</i>/<i>z</i> 547 [M + 1]<sup>+</sup>, rt = 1.96 min.</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-<i>N</i>-(3-(4-Amino-6-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)pyrimidin-5-yl)phenyl)methanesulfonamide (<b>21</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12b</b> and <i>N</i>-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide in 18% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.07 (s, 1H), 7.51 (d, <i>J</i> = 7.2 Hz, 5H), 7.38–7.20 (m, 5H), 7.13 (s, 1H), 6.31 (d, <i>J</i> = 2.6 Hz, 1H), 4.92 (dd, <i>J</i> = 31.2, 24.6 Hz, 2H), 4.54 (s, 2H), 3.08 (s, 3H), 2.48 (s, 3H), 1.24 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 531 [M + 1]<sup>+</sup>, rt = 2.11 min.</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-2-(1-((6-Amino-5-(1<i>H</i>-indol-6-yl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">White solid. Prepared from <b>12b</b> and (1<i>H</i>-indol-6-yl)boronic acid in 14% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.52 (s, 1H), 8.03 (d, <i>J</i> = 11.4 Hz, 1H), 7.83 (dd, <i>J</i> = 24.4, 8.0 Hz, 1H), 7.59–7.40 (m, 4H), 7.33 (s, 1H), 7.13 (dd, <i>J</i> = 10.1, 5.3 Hz, 1H), 7.08–6.95 (m, 1H), 6.65 (s, 1H), 6.29 (d, <i>J</i> = 6.6 Hz, 1H), 5.21–4.87 (m, 4H), 4.39 (s, 2H), 2.47 (d, <i>J</i> = 1.8 Hz, 3H), 1.22 (dd, <i>J</i> = 10.2, 6.1 Hz, 3H). LRMS <i>m</i>/<i>z</i> 475 [M – 1]<sup>−</sup>, rt = 2.50 min.</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-5-(4-Amino-6-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)pyrimidin-5-yl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p last">White solid. Obtained as an unexpected reaction product from <b>12b</b> and 1-(2-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea in 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.81 (d, <i>J</i> = 15.0 Hz, 1H), 7.67–7.26 (m, 7H), 6.96 (s, 1H), 6.82 (s, 1H), 6.41 (d, <i>J</i> = 19.8 Hz, 1H), 5.57 (s, 3H), 4.76 (s, 2H), 2.38 (d, <i>J</i> = 12.6 Hz, 3H), 1.22 (dd, <i>J</i> = 16.9, 6.7 Hz, 3H). LRMS <i>m</i>/<i>z</i> 495 [M + 1]<sup>+</sup>, rt = 2.08 min.</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-2-(1-((6-Amino-5-(3-hydroxybenzyl)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last">Prepared from <b>12a</b> and 2-(3-methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. The product obtained from the coupling reaction was demethylated by treatment with 1 M BBr<sub>3</sub> solution in DCM at room temperature overnight. The reaction mixture was diluted with EtOAc and washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvents were removed. The product was purified by reverse phase chromatography. Compound <b>24</b> was obtained in 14% yield (two steps) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (s, 1H), 7.56–7.38 (m, 5H), 7.23–7.15 (m, 2H), 6.83 (d, <i>J</i> = 7.6 Hz, 1H), 6.74 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.63 (s, 1H), 6.31 (d, <i>J</i> = 2.2 Hz, 1H), 5.14 (d, <i>J</i> = 8.6 Hz, 1H), 5.01–4.80 (m, 3H), 3.71–3.58 (m, 2H), 2.62 (s, 1H), 2.52–2.43 (m, 3H), 1.25 (d, <i>J</i> = 6.7 Hz, 3H). LRMS <i>m</i>/<i>z</i> 468 [M + 1]<sup>+</sup>, rt= 2.15 min.</div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-2-(1-((6-Amino-5-((3-hydroxyphenyl)thio)pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">Compound <b>12b</b> (100 mg, 0.21 mmol) was dissolved in 7 mL of DMF in a pressure reactor. 3-Mercaptophenol (39 mg, 0.31 mmol), K<sub>2</sub>CO<sub>3</sub> (128 mg, 0.93 mmol), and CuI (59 mg, 0.31 mmol) were added, and the reaction mixture was heated under argon at 70 °C overnight. The reaction mixture was partitioned between EtOAc and water, and the organic phase was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography (0–100% hexane–EtOAc) to give 30 mg (30% yield) of <b>25</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 7.53–7.35 (m, 4H), 7.30–7.28 (m, 1H), 7.16–7.12 (m, 2H), 6.82 (ddd, <i>J</i> = 7.8, 1.7, 0.9 Hz, 1H), 6.66 (ddd, <i>J</i> = 8.1, 2.4, 0.9 Hz, 1H), 6.44–6.37 (m, 1H), 6.32 (dd, <i>J</i> = 2.7, 0.6 Hz, 1H), 6.24 (d, <i>J</i> = 8.4 Hz, 1H), 5.25 (s, 2H), 4.90 (dq, <i>J</i> = 13.6, 6.8 Hz, 1H), 2.50 (s, 3H), 1.31–1.27 (m, 3H). LRMS <i>m</i>/<i>z</i> 486 [M + 1]<sup>+</sup>, rt = 2.68 min.</div></div><div id="sec6_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-4-Amino-<i>N</i>-(3-hydroxyphenyl)-6-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)pyrimidine-5-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Compound <b>13</b> (300 mg, 0.51 mmol) was dissolved in 7 mL of DMF. DIEA (150 μL, 1.10 mmol) and HATU (400 mg, 1.05 mmol) were added, and the reaction mixture was stirred at r.t. for 30 min. Then, 3-methoxyaniline (95 μL, 0.85 mmol) was added and the reaction mixture stirred at r.t. overnight. The crude reaction mixture was diluted with water and extracted with EtOAc. The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure.The semisolid obtained was purified by column chromatography (0–50% hexane–EtOAc). The intermediate product was dissolved in 5 mL of TFA and stirred at r.t. overnight. The TFA was evaporated, and the residue was partitioned between EtOAc and water. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a solid that was treated with a 1 M solution of BBr<sub>3</sub> in DCM (160 μL, 0.16 mmol). After stirring for 2 h, the reaction mixture was diluted with EtOAc and washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvents were removed. The product was purified by reverse phase chromatography to yield <b>26</b> (global yield 5%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1H), 8.03 (s, 1H), 7.63–7.46 (m, 5H), 7.40–7.29 (m, 2H), 7.23–7.07 (m, 2H), 7.02–6.92 (m, 1H), 6.74–6.57 (m, 2H), 6.28 (d, <i>J</i> = 2.6 Hz, 1H), 6.02 (s, 2H), 5.03 (p, <i>J</i> = 6.8 Hz, 1H), 2.46 (s, 3H), 1.35 (d, <i>J</i> = 6.8 Hz, 3H). LRMS <i>m</i>/<i>z</i> 497 [M + 1]<sup>+</sup>, rt = 2.36 min.</div></div><div id="sec6_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-2-(1-((5-Bromo-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>28</b>)</h4><div class="NLM_p last">Compound <b>9</b> (8.34 g, 21.9 mmol), 5-bromo-4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine <b>27</b> (11.0 g, 30.30 mmol) and CsF (2.9 g, 19.1 mmol) were suspended in 225 mL of <i>t</i>BuOH. DIEA (32.5 mL, 187.00 mmol) was added, and the mixture was stirred at 95 °C in a sealed vessel for 96 h. The reaction mixture was concentrated and the residue partitioned between water and EtOAc, and the organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and filtered and the solvents were evaporated. The product was purified by flash chromatography (0–70% hexane–EtOAc) to furnish 7.85 g (60% yield) of <b>28</b>. LRMS <i>m</i>/<i>z</i> 595 [M + 1]<sup>+</sup>.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Synthesis of Compounds <b>32</b>–<b>45</b></h3><div class="NLM_p">The following compounds were prepared according to the procedure described for compound <b>14</b> followed by subsequent deprotection of the SEM group using a two-step protocol: treatment of the SEM-protected compounds with TFA at r.t., evaporation of the TFA, and then treatment of the residue with a 7 M solution of NH<sub>3</sub> in MeOH at r.t. until deprotection were completed. Any variations used in solvents or catalyst from the general procedure are described in each example.</div><div id="sec6_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>S</i>)-2-(1-((5-(2-Hydroxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>32</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (3-hydroxy-5-(trifluoromethyl)phenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 36% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.75 (s, 1H), 9.86 (s, 1H), 8.08 (s, 1H), 7.62–7.47 (m, 5H), 7.31–7.21 (m, 3H), 7.12 (d, <i>J</i> = 2.4 Hz, 1H), 7.03 (d, <i>J</i> = 7.8 Hz, 1H), 6.96–6.88 (m, 1H), 6.40 (d, <i>J</i> = 2.6 Hz, 1H), 6.37 (d, <i>J</i> = 7.3 Hz, 1H), 4.79–4.67 (m, 1H), 2.37 (s, 3H), 1.27 (d, <i>J</i> = 6.3 Hz, 3H). LRMS <i>m</i>/<i>z</i> 478 [M + 1]<sup>+</sup>, rt = 2.80 min.</div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>S</i>)-2-(1-((5-(2-Hydroxy-3-methoxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>33</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (2-hydroxy-3-methoxyphenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.75 (bs, 1H), 8.90 (bs, 1H), 8.08 (s, 1H), 7.59–7.47 (m, 5H), 7.22 (d, <i>J</i> = 2.3 Hz, 1H), 7.13–7.02 (m, 2H), 6.94–6.85 (m, 2H), 6.41 (d, <i>J</i> = 2.3 Hz, 1H), 6.26 (d, <i>J</i> = 6.3 Hz, 1H), 4.82–4.64 (m, 1H), 3.83 (s, 3H), 2.38 (s, 3H), 1.26 (d, <i>J</i> = 6.3 Hz, 3H). LRMS <i>m</i>/<i>z</i> 508 [M + 1]<sup>+</sup>, rt = 2.86 min.</div></div><div id="sec6_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-2-(1-((5-(3-Fluoro-2-hydroxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>34</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (3-fluoro-2-methoxyphenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. Demethylation of the product of the Suzuki reaction was achieved by treatment with a 1 M solution of BBr<sub>3</sub> in DCM at r.t. followed by a final treatment with 7 M NH<sub>3</sub> in MeOH to give <b>34</b> in 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 9.86 (bs, 1H), 8.08 (s, 1H), 7.61–7.45 (m, 5H), 7.31–7.21 (m, 1H), 7.19 (d, <i>J</i> = 2.6 Hz, 1H), 7.16 (d, <i>J</i> = 2.0 Hz, 1H), 7.09 (d, <i>J</i> = 7.3 Hz, 1H), 6.98–6.83 (m, 1H), 6.39 (d, <i>J</i> = 2.5 Hz, 1H), 6.15 (bs, 1H), 4.80–4.67 (m, 1H), 2.36 (s, 3H), 1.24 (d, <i>J</i> = 6.5 Hz, 3H). LRMS <i>m</i>/<i>z</i> 496 [M + 1]<sup>+</sup>, rt = 2.86 min.</div></div><div id="sec6_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>S</i>)-2-(1-((5-(2-Hydroxy-5-(trifluoromethyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>35</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (2-methoxy-5-(trifluoromethyl)phenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. Demethylation of the product of the Suzuki reaction was achieved by treatment with a 1 M solution of BBr<sub>3</sub> in DCM at r.t. followed by a final treatment with 7 M NH<sub>3</sub> in MeOH gave <b>35</b> in 9% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (bs, 1H), 10.89 (bs, 1H), 8.08 (s, 1H), 7.65–7.42 (m, 6H), 7.30–6.99 (m, 4H), 6.38 (d, <i>J</i> = 2.3 Hz, 1H), 6.03 (bs, 1H), 4.79–4.61 (m, 1H), 2.37 (s, 3H), 1.27 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 546 [M + 1]<sup>+</sup>, rt = 3.27 min.</div></div><div id="sec6_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-2-(1-((5-(4-Hydroxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>36</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (4-hydroxyphenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (bs, 1H), 9.65 (s, 1H), 8.12 (s, 1H), 7.64–7.47 (m, 5H), 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 7.26 (d, <i>J</i> = 2.5 Hz, 1H), 7.15 (d, <i>J</i> = 2.2 Hz, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 2H), 6.41 (d, <i>J</i> = 2.1 Hz, 1H), 5.92 (d, <i>J</i> = 7.5 Hz, 1H), 4.89–4.76 (m, 1H), 2.38 (s, 3H), 1.26 (d, <i>J</i> = 6.5 Hz, 3H). LRMS <i>m</i>/<i>z</i> 478 [M + 1]<sup>+</sup>, rt = 2.57 min.</div></div><div id="sec6_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>S</i>)-2-(1-((5-(4-Hydroxy-3-methoxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>37</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol in a 4:1 mixture of DME/water as solvent. 31% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (bs, 1H), 9.21 (bs, 1H), 8.13 (s, 1H), 7,65–7,48 (m, 5H), 7.24 (d, <i>J</i> = 2.4 Hz, 1H), 7.18 (d, <i>J</i> = 2.0 Hz, 1H), 7.10 (s, 1H), 6.91 (s, 2H), 6.40 (d, <i>J</i> = 2.0 Hz, 1H), 6.10 (d, <i>J</i> = 7.3 Hz, 1H), 4.87–4.74 (m, 1H), 3.85 (s, 3H), 2.37 (s, 3H), 1.29 (d, <i>J</i> = 6.5 Hz, 3H). LRMS <i>m</i>/<i>z</i> 508 [M + 1]<sup>+</sup>, rt = 3.02 min.</div></div><div id="sec6_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>S</i>)-2-(1-((5-(3-Fluoro-5-hydroxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>38</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (3-fluoro-5-hydroxyphenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.96 (s, 1H), 10.16 (bs, 1H), 8.15 (s, 1H), 7.65–7.48 (m, 5H), 7.34 (d, <i>J</i> = 2.4 Hz, 1H), 7.28 (d, <i>J</i> = 2.6 Hz, 1H), 6.88–6.75 (m, 2H), 6.67–6.57 (m, 1H), 6.41 (d, <i>J</i> = 2.6, 1H), 6.11 (d, <i>J</i> = 7.4 Hz, 1H), 4.92–4.79 (m, 1H), 2.38 (s, 3H), 1.31 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 496 [M + 1]<sup>+</sup>, rt = 2.91 min.</div></div><div id="sec6_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>S</i>)-<i>N</i>-(3-Hydroxy-5-(4-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)phenyl)methanesulfonamide (<b>39</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and <i>N</i>-(3-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide in a 4:1 mixture of DME/water as solvent. 29% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (bs, 1H), 9.75 (bs, 1H), 8.10 (s, 1H), 7.59–7.45 (m, 6H), 7.29 (d, <i>J</i> = 2.6 Hz, 1H), 7.20 (d, <i>J</i> = 2.2 Hz, 1H), 6.77–6.69 (m, 2H), 6.62 (s, 1H), 6.37 (d, <i>J</i> = 2.6 Hz, 1H), 6.05 (d, <i>J</i> = 7.3 Hz, 1H), 4.85–4.74 (m, <i>J</i> = 6.6 Hz, 1H), 2.97 (s, 3H), 2.35 (s, 3H), 1.30 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 571 [M + 1]<sup>+</sup>, rt = 2.18 min.</div></div><div id="sec6_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>)-<i>N</i>-(3-(4-((1-(5-Methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)phenyl)methanesulfonamide (<b>40</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (3-(methylsulfonamido)phenyl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 26% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.89 (bs, 1H), 8.14 (s, 1H), 7.62–7.49 (m, 5H), 7.45–7.34 (m, 2H), 7.32–7.21 (m, 2H), 7.21–7.09 (m, 2H), 6.38 (d, <i>J</i> = 2.7 Hz, 1H), 5.98 (bs, 1H), 4.87–4.75 (m, 1H), 3.00–2.85 (m, 4H), 2.37 (s, 3H), 1.30 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 555 [M + 1]<sup>+</sup>, rt = 2.56 min.</div></div><div id="sec6_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-2-(1-((5-(1<i>H</i>-Indol-7-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>41</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (1<i>H</i>-indol-7-yl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 9% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.97 (bs, 1H), 10.98 (bs, 1H), 8.17 (s, 1H), 7.68–7.61 (m, 1H), 7.60–7.46 (m, 5H), 7.37 (d, <i>J</i> = 2.3 Hz, 1H), 7.33–7.28 (m, 1H), 7.19–7.11 (m, 3H), 6.56–6.48 (m, 1H), 6.37 (d, <i>J</i> = 2.6 Hz, 1H), 5.71 (d, <i>J</i> = 7.3 Hz, 1H), 4.78–4.65 (m, 1H), 2.35 (s, 3H), 1.25 (d, <i>J</i> = 6.3 Hz, 3H). LRMS <i>m</i>/<i>z</i> 501 [M + 1]<sup>+</sup>, rt = 3.26 min.</div></div><div id="sec6_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-2-(1-((5-(1<i>H</i>-Indol-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>42</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indole using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 29% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.89 (bs, 1H), 11.32 (bs, 1H), 8.15 (s, 1H), 7.60–7.46 (m, 6H), 7.41–7.36 (m, 1H), 7.33–7.28 (m, 1H), 7.26–7.20 (m, 1H), 7.13 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (d, <i>J</i> = 7.1 Hz, 1H), 6.44–6.39 (m, 1H), 6.37 (d, <i>J</i> = 2.7 Hz, 1H), 5.89 (d, <i>J</i> = 7.3 Hz, 1H), 4.77–4.66 (m, 1H), 2.35 (s, 3H), 1.13 (d, <i>J</i> = 6.4 Hz, 3H). LRMS <i>m</i>/<i>z</i> 501 [M + 1]<sup>+</sup>, rt = 2.74 min.</div></div><div id="sec6_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>S</i>)-2-(1-((5-(1<i>H</i>-Pyrazol-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>43</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and (1<i>H</i>-pyrazol-4-yl)boronic acid using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 27% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.15 (bs, 1H), 11.76 (s, 1H), 8.11 (s, 1H), 8.01–7.95 (m, 1H), 7.79–7.72 (m, 1H), 7.63–7.50 (m, 5H), 7.48 (d, <i>J</i> = 2.6 Hz, 1H), 7.15 (d, <i>J</i> = 2.4 Hz, 1H), 6.43 (d, <i>J</i> = 2.4 Hz, 1H), 6.17 (d, <i>J</i> = 7.4 Hz, 1H), 4.89–4.79 (m, 1H), 2.38 (s, 3H), 1.28 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 452 [M + 1]<sup>+</sup>, rt = 2.20 min.</div></div><div id="sec6_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-5-Methyl-2-(1-((5-(1-methyl-1<i>H</i>-pyrazol-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>44</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole using Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> as catalyst in a 4:1 mixture of DME/water as solvent. 63% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.75 (bs, 1H), 8.11 (s, 1H), 7.89 (s, 1H), 7.69 (d, <i>J</i> = 0.8 Hz, 1H), 7.62–7.50 (m, 5H), 7.45 (d, <i>J</i> = 2.6 Hz, 1H), 7.13 (d, <i>J</i> = 1.9 Hz, 1H), 6.42 (d, <i>J</i> = 2.6 Hz, 1H), 6.12 (d, <i>J</i> = 7.3 Hz, 1H), 4.90–4.78 (m, 1H), 3.92 (s, 3H), 2.39 (s, 3H), 1.30 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 466 [M +1]<sup>+</sup>, rt = 2.57 min.</div></div><div id="sec6_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>S</i>)-2-(1-((5-(3-Hydroxybenzyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>45</b>)</h4><div class="NLM_p last">Prepared from <b>28</b> and 2-(3-methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. Demethylation of the product of the Suzuki reaction was achieved by treatment with a 1 M solution of BBr<sub>3</sub> in DCM at r.t. and followed by a final treatment with 7 M NH<sub>3</sub> in MeOH to give <b>45</b> in 29% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.71 (s, 1H), 7.98 (s, 1H), 7.46 (m, 1H), 7.34 (m, 1H), 7.29 (d, <i>J</i> = 2.6 Hz, 1H), 7.14 (m, 3H), 6.92 (m, 1H), 6.84 (m, 1H), 6.76 (s, 1H), 6.65 (s, 1H), 6.58 (d, <i>J</i> = 7.6 Hz, 1H), 6.34 (d, <i>J</i> = 2.7 Hz, 1H), 5.12 (d, <i>J</i> = 8.3 Hz, 1H), 4.91 (m, 1H), 4.05 (dd, <i>J</i> = 41.2, 16.7 Hz, 2H), 2.50 (s, 3H), 1.22 (d, <i>J</i> = 6.7 Hz, 3H). LRMS <i>m</i>/<i>z</i> 492 [M + 1]<sup>+</sup>, rt = 2.73 min.</div></div><div id="sec6_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>S</i>)-2-(1-((5-((3-Hydroxyphenyl)thio)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>46</b>)</h4><div class="NLM_p last">Compound <b>9</b> (60 mg, 0.22 mmol) and 4-chloro-5-((3-methoxyphenyl)thio)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (109 mg, 0.26 mmol) were dissolved in <i>t</i>BuOH. DIEA (195 μL, 1.12 mmol) was added, and the reaction mixture was heated at 120 °C overnight. After evaporation of the solvent, the crude intermediate was purified by flash chromatography (0–50% hexane–EtOAc). Demethylation of this intermediate compounds was achieved by treatment with a 1 M solution of BBr<sub>3</sub> in DCM at r.t. followed by a final treatment with 7 M NH<sub>3</sub> in MeOH to give <b>46</b> in 26% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.23 (bs, 1H), 9.50 (bs, 1H), 8.08 (s, 1H), 7.62 (s, 1H), 7.58–7.35 (m, 4H), 7.34 (d, <i>J</i> = 2.4 Hz, 1H), 7.30–7.23 (m, 1H), 6.94–6.86 (m, 1H), 6.67–6.56 (m, 2H), 6.51–6.43 (m, 2H), 6.41 (d, <i>J</i> = 2.4 Hz, 1H), 4.84–4.71 (m, 1H), 2.38 (s, 3H), 1.19 (d, <i>J</i> = 6.6 Hz, 3H). LRMS <i>m</i>/<i>z</i> 510 [M + 1]<sup>+</sup>, rt = 3.21 min.</div></div><div id="sec6_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>S</i>)-4-((1-(5-Methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carboxylic acid (<b>31</b>)</h4><div class="NLM_p last">Compound <b>9</b> (418 mg, 1.56 mmol) and benzyl 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carboxylate <b>30</b> (500 mg, 1.74 mmol) were dissolved in <i>t</i>-BuOH (8 mL), and DIEA (2 mL, 11.50 mmol) was added. After stirring the mixture at 80 °C for 12 h, the solvent was evaporated under reduced pressure and the residue was suspended in water, basified with Na<sub>2</sub>CO<sub>3</sub>, and extracted with AcOEt. The organic phase was washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and the solvent evaporated under reduced pressure. The intermediate was purified by column chromatography (0–50%, hexane–EtOAc). The intermediate compounds were dissolved in MeOH (200 mL) and hydrogenated in a Parr apparatus at 25 psi in the presence of 10% Pd/C. Once the reaction was complete, the mixture was filtered and the solvent evaporated under reduced pressure to yield 376 mg (52% yield) of <b>31</b>. LRMS <i>m</i>/<i>z</i> 430 [M + 1]<sup>+</sup>.</div></div><div id="sec6_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>S</i>)-<i>N</i>-(3-Hydroxyphenyl)-4-((1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carboxamide (<b>47</b>)</h4><div class="NLM_p last">Compound <b>31</b> (25 mg, 0.06 mmol), 3-aminophenol (7 mg, 0.07 mmol), and DIEA (41 μL, 0.23 mmol) were dissolved in DMF (1.5 mL) and stirred for 30 min. Then, T3P (50% in DMF, 140 μL, 0.24 mmol) was added dropwise and the reaction mixture stirred overnight at r.t. The mixture was poured into ice and extracted with EtOAc, and the organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and filtered, and the solvents were evaporated. The product was purified by flash chromatography (0–5% DCM–MeOH) to give 2 mg (6% yield) of <b>47</b>. LRMS <i>m</i>/<i>z</i> 521 [M + 1]<sup>+</sup>, rt = 3.02 min.</div></div><div id="sec6_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>S</i>)-2-(1-((5-(6-Amino-1<i>H</i>-indol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)-5-methyl-3-phenylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (<b>49</b>)</h4><div class="NLM_p last">A 1.82 g (3.06 mmol) amount of <b>28</b>, 1.00 g (3.87 mmol) of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indol-6-amine <b>48</b>, 522 mg (4.93 mmol) of Na<sub>2</sub>CO<sub>3</sub>, and 750 mg (0.92 mmol) of PdCl<sub>2</sub>(dppf)<sub>2</sub>·DCM were suspended in a mixture of 40 mL of DME and 10 mL of water. The mixture was stirred under an argon atmosphere at 90 °C for 16 h, and then the organics were evaporated. The resulting suspension was extracted with EtOAc, and the organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered and the solvent was removed under reduced pressure. The product was purified by flash chromatography (0–60% hexane–EtOAc) to give 1.10 g (52% yield) of <b>49</b> as a pale yellow solid.</div></div><div id="sec6_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-[4-(4-{[(1<i>S</i>)-1-(5-Methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)ethyl]amino}-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)-1<i>H</i>-indol-6-yl]sulfamide (LAS195319)</h4><div class="NLM_p last">Compound <b>49</b> (1.10 g, 1.70 mmol) was treated with pyridine (0.50 mL, 6.13 mmol) and sulfamoyl chloride (450 mg, 3.89 mmol) in tetrahydrofuran (30 mL) at 0 °C. After complete addition of the reagents, the mixture was stirred overnight, the solvent was evaporated, and the residue was partitioned between water and EtOAc. The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure. The intermediate compound obtained was deprotected using the method as described above for the synthesis of compounds <b>32</b>–<b>45</b>. Purification of the crude product by reverse phase chromatography furnished 910 mg (69% yield) of LAS195319. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.86 (bs, 1H), 11.16 (bs, 1H), 9.24 (bs, 1H), 8.14 (s, 1H), 7.58–7.44 (m, 7H), 7.38–7.33 (m, 1H), 7.28–7.24 (m, 1H), 7.22 (d, <i>J</i> = 2.3 Hz, 1H), 7.14 (d, <i>J</i> = 2.6 Hz, 1H), 6.93 (bs, 2H), 6.32 (d, <i>J</i> = 2.0 Hz, 1H), 5.84 (d, <i>J</i> = 6.7 Hz, 1H), 4.68–4.57 (m, 1H), 2.33 (s, 3H), 1.15 (d, <i>J</i> = 6.5 Hz, 3H). LRMS <i>m</i>/<i>z</i> 595 [M + 1]<sup>+</sup>, rt = 2.08 min. HRMS (ES<sup>+</sup>) for C<sub>29</sub>H<sub>27</sub>N<sub>10</sub>O<sub>3</sub>S [M + H]<sup>+</sup> calculated 595.1983, found 595.1979.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00873" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00873" class="ext-link">10.1021/acs.jmedchem.8b00873</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Assays procedures, full selectivity panel for compound <b>50</b>, and characterization data for the most advanced compounds <b>15</b> and <b>50</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_001.csv">jm8b00873_si_001.csv (4.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_002.pdf">jm8b00873_si_002.pdf (766.97 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors are deposited in the Protein Data Bank and will be released upon publication. PDB IDs have been provided in figure legends (<b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U">5M6U</a>; <b>39</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W">6G6W</a>)</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00873" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Montse Erra</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8753-8692" title="Orcid link">http://orcid.org/0000-0002-8753-8692</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#137e7c7d6760763d7661617253727f7e7a61727f7f3d707c7e"><span class="__cf_email__" data-cfemail="b6dbd9d8c2c5d398d3c4c4d7f6d7dadbdfc4d7dada98d5d9db">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joan Taltavull</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5199-5349" title="Orcid link">http://orcid.org/0000-0002-5199-5349</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Javier Bernal</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Francisco Caturla</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Carrascal</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lluís Pagès</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3367-9529" title="Orcid link">http://orcid.org/0000-0002-3367-9529</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Mir</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sònia Espinosa</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jordi Gràcia</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7470-6933" title="Orcid link">http://orcid.org/0000-0002-7470-6933</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Domínguez</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Metabolism, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mar Sabaté</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Metabolism, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stéphane Paris</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Bionure Farma, Parc Científic de Barcelona, Balidiri Reixac 4–8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mónica Maldonado</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Begoña Hernández</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry and Screening, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Palobiofarma SL, Plaza CEIN, Polígono Industrial Mocholí, 31110 Noain, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mónica Bravo</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic
Area, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Calama</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic
Area, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Montserrat Miralpeix</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic
Area, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Galápagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin D. Lehner</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic
Area, , and , Almirall R&D, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Bionorica SE, Kerschensteinerstraße 11–15, 92318 Neumarkt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Calbet</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic
Area, , and , Almirall R&D, 08980 Barcelona, Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors were Almirall full-time employees when this study was performed.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4308-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Proteros Biostructures GmbH for X-ray structure determination of human PI3Kδ in complex with compound <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U">5M6U</a>) and in complex with compound <b>39</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W">6G6W</a>). We also acknowledge the significant technical support provided by Fèlix Gil, Jordi Serrat, Gaspar Casals, Jordi Sanahuja, and Antonia Molina. Finally, we  thank Paul Eastwood, Josep Ma̲ Huerta, Carme Serra, and Victor Segarra for their help in the preparation of this manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">M-CSF</td><td class="NLM_def"><p class="first last">macrophage colony-stimulating factor</p></td></tr><tr><td class="NLM_term">OVA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol-4,5-bisphosphate-3-kinase</p></td></tr><tr><td class="NLM_term">PIP2</td><td class="NLM_def"><p class="first last">phosphatidylinositol 4,5-bisphosphate</p></td></tr><tr><td class="NLM_term">PIP3</td><td class="NLM_def"><p class="first last">phosphatidylinositol (3,4,5)-trisphosphate</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 12 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.</span></span> <span> </span><span class="NLM_article-title">PI3K signaling: the path to discovery and understanding</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/nrm3290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1038%2Fnrm3290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=22358332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1eqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=195-203&issue=3&author=B.+Vanhaesebroeckauthor=L.+Stephensauthor=P.+Hawkins&title=PI3K+signaling%3A+the+path+to+discovery+and+understanding&doi=10.1038%2Fnrm3290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K signalling: The path to discovery and understanding</span></div><div class="casAuthors">Vanhaesebroeck, Bart; Stephens, Len; Hawkins, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Over the past two decades, our understanding of phosphoinositide 3-kinases (PI3Ks) has progressed from the identification of an enzymic activity assocd. with growth factors, GPCRs and certain oncogene products to a disease target in cancer and inflammation, with PI3K inhibitors currently in clin. trials.  Elucidation of PI3K-dependent networks led to the discovery of the phosphoinositide-binding PH, PX and FYVE domains as conduits of intracellular lipid signalling, the detn. of the mol. function of the tumor suppressor PTEN and the identification of AKT and mTOR protein kinases as key regulators of cell growth.  Here we look back at the main discoveries that shaped the PI3K field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WDc7Z5rhLLVg90H21EOLACvtfcHk0lgoFBxhO2OKkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1eqt7s%253D&md5=ff960f9ebfb5b5f2d8fc214aba330eef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3290%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%26atitle%3DPI3K%2520signaling%253A%2520the%2520path%2520to%2520discovery%2520and%2520understanding%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26issue%3D3%26spage%3D195%26epage%3D203%26doi%3D10.1038%2Fnrm3290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affleck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span> <span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for allergic asthma</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1042/BST20110665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1042%2FBST20110665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=22260698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=240-245&issue=1&author=W.+C.+Rowanauthor=J.+L.+Smithauthor=K.+Affleckauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+allergic+asthma&doi=10.1042%2FBST20110665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for allergic asthma</span></div><div class="casAuthors">Rowan, Wendy C.; Smith, Janet L.; Affleck, Karen; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-245</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation in the lung has long been linked to the pathogenesis of asthma.  Central to this airway inflammation is a T-cell response to allergens, with Th2 cytokines driving the differentiation, survival and function of the major inflammatory cells involved in the allergic cascade.  PI3Kδ (phosphoinositide 3-kinase δ) is a lipid kinase, expressed predominantly in leukocytes, where it plays a crit. role in immune receptor signalling.  A selective PI3Kδ inhibitor is predicted to block T-cell activation in the lung, reducing the prodn. of pro-inflammatory Th2 cytokines.  PI3Kδ is also involved in B-cell and mast cell activation.  Therefore the inhibition of PI3Kδ should dampen down the inflammatory cascade involved in the asthmatic response through a wide breadth of pharmacol.  Current anti-inflammatory therapies, which are based on corticosteroids, are effective in controlling inflammation in mild asthmatics, but moderate/severe asthmatic patients remain poorly controlled, experiencing recurrent exacerbations.  Corticosteroids have no effect on mast cell degranulation and do not act directly on B-cells, so, overall, a PI3Kδ inhibitor has the potential to deliver improvements in onset of action, efficacy and reduced exacerbations in moderate/severe asthmatics.  Addnl., PI3Kδ inhibition is expected to block effects of Th17 cells, which are increasingly implicated in steroid-insensitive asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwu2SYlFjDbVg90H21EOLACvtfcHk0lgoFBxhO2OKkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D&md5=db36bc8f79c70e0817e00fb9b04f10ff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2FBST20110665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110665%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520allergic%2520asthma%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26issue%3D1%26spage%3D240%26epage%3D245%26doi%3D10.1042%2FBST20110665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sriskantharajah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calver, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessel, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span> <span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1280</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1111/nyas.12039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1111%2Fnyas.12039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=23551101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1280&publication_year=2013&pages=35-39&author=S.+Sriskantharajahauthor=N.+Hamblinauthor=S.+Worsleyauthor=A.+R.+Calverauthor=E.+M.+Hesselauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+the+treatment+of+respiratory+diseases&doi=10.1111%2Fnyas.12039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span></div><div class="casAuthors">Sriskantharajah, Srividya; Hamblin, Nicole; Worsley, Sally; Calver, Andrew R.; Hessel, Edith M.; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1280</span>
        (<span class="NLM_cas:issue">Inositol Phospholipid Signaling in Physiology and Disease</span>),
    <span class="NLM_cas:pages">35-39</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Asthma and chronic obstructive pulmonary disease (COPD) are characterized in their pathogenesis by chronic inflammation in the airways.  Phosphoinositide 3-kinase δ (PI3Kδ), a lipid kinase expressed predominantly in leukocytes, is thought to hold much promise as a therapeutic target for such inflammatory conditions.  Of particular interest for the treatment of severe respiratory disease is the observation that inhibition of PI3Kδ may restore steroid effectiveness under conditions of oxidative stress.  PI3Kδ inhibition may also prevent recruitment of inflammatory cells, including T lymphocytes and neutrophils, as well as the release of proinflammatory mediators, such as cytokines, chemokines, reactive oxygen species, and proteolytic enzymes.  In addn., targeting the PI3Kδ pathway could reduce the incidence of pathogen-induced exacerbations by improving macrophage-mediated bacterial clearance.  In this review, we discuss the potential and highlight the unknowns of targeting PI3Kδ for the treatment of respiratory disease, focusing on recent developments in the role of the PI3Kδ pathway in inflammatory cell types believed to be crit. to the pathogenesis of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa4PRY73w17Vg90H21EOLACvtfcHk0lhJfOzryDJm9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D&md5=51549242bdf01d3373ded21565656f1d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fnyas.12039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.12039%26sid%3Dliteratum%253Aachs%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DHamblin%26aufirst%3DN.%26aulast%3DWorsley%26aufirst%3DS.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520the%2520treatment%2520of%2520respiratory%2520diseases%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1280%26spage%3D35%26epage%3D39%26doi%3D10.1111%2Fnyas.12039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="note"><p class="first last">Zydelig prescribing information.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span> <span> </span><span class="NLM_article-title">Optimisation of DMPK by inhaled route: Challenges and approaches</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=A.+E.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+inhaled+route%3A+Challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0lhJfOzryDJm9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520inhaled%2520route%253A%2520Challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span>RV1729
and RV6153 (RespiVert) and GSK2269557 (GSK) at <a href="http://clinicaltrials.gov" class="extLink">clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=RV1729%0Aand+RV6153+%28RespiVert%29+and+GSK2269557+%28GSK%29+at+clinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gréco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caturla, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gràcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armengol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabedo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, M. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective, and orally available PI3Kδ inhibitor for the treatment of inflammatory diseases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=118-123&issue=1&author=M.+Erraauthor=J.+Taltavullauthor=A.+Gr%C3%A9coauthor=F.+J.+Bernalauthor=J.+F.+Caturlaauthor=J.+Gr%C3%A0ciaauthor=M.+Dom%C3%ADnguezauthor=M.+Sabat%C3%A9author=S.+Parisauthor=S.+Soriaauthor=B.+Hern%C3%A1ndezauthor=C.+Armengolauthor=J.+Cabedoauthor=M.+Bravoauthor=E.+Calamaauthor=M.+Miralpeixauthor=M.+D.+Lehner&title=Discovery+of+a+potent%2C+selective%2C+and+orally+available+PI3K%CE%B4+inhibitor+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facsmedchemlett.6b00438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00438%26sid%3Dliteratum%253Aachs%26aulast%3DErra%26aufirst%3DM.%26aulast%3DTaltavull%26aufirst%3DJ.%26aulast%3DGr%25C3%25A9co%26aufirst%3DA.%26aulast%3DBernal%26aufirst%3DF.%2BJ.%26aulast%3DCaturla%26aufirst%3DJ.%2BF.%26aulast%3DGr%25C3%25A0cia%26aufirst%3DJ.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DM.%26aulast%3DSabat%25C3%25A9%26aufirst%3DM.%26aulast%3DParis%26aufirst%3DS.%26aulast%3DSoria%26aufirst%3DS.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DArmengol%26aufirst%3DC.%26aulast%3DCabedo%26aufirst%3DJ.%26aulast%3DBravo%26aufirst%3DM.%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520PI3K%25CE%25B4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D118%26epage%3D123%26doi%3D10.1021%2Facsmedchemlett.6b00438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span> <span> </span><span class="NLM_article-title">The p110δ structure: mechanisms for selectivity and potency of new PI(3)k inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.+C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williamsauthor=P.+Ren&title=The+p110%CE%B4+structure%3A+mechanisms+for+selectivity+and+potency+of+new+PI%283%29k+inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0li027pk0TREGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DRen%26aufirst%3DP.%26atitle%3DThe%2520p110%25CE%25B4%2520structure%253A%2520mechanisms%2520for%2520selectivity%2520and%2520potency%2520of%2520new%2520PI%25283%2529k%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkel, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1016%2Fj.chembiol.2010.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=20189103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1Wksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=123-134&issue=2&author=O.+Williamsauthor=B.+T.+Housemanauthor=E.+J.+Kunkelauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=Z.+A.+Knightauthor=K.+M.+Shokat&title=Discovery+of+dual+inhibitors+of+the+immune+cell+PI3Ks+p110delta+and+p110gamma%3A+a+prototype+for+new+anti-inflammatory+drugs&doi=10.1016%2Fj.chembiol.2010.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Dual Inhibitors of the Immune Cell PI3Ks p110δ and p110γ: A Prototype for New Anti-inflammatory Drugs</span></div><div class="casAuthors">Williams, Olusegun; Houseman, Benjamin T.; Kunkel, Eric J.; Aizenstein, Brian; Hoffman, Randy; Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PI3Kδ and PI3Kγ regulate immune cell signaling, while the related PI3Kα and PI3Kβ regulate cell survival and metab.  Selective inhibitors of PI3Kδ/γ represent a potential class of anti-inflammatory agents lacking the antiproliferative effects assocd. with PI3Kα/β inhibition.  Here we report the discovery of PI3Kδ/γ inhibitors that display up to 1000-fold selectivity over PI3Kα/β and evaluate these compds. in a high-content inflammation assay using mixts. of primary human cells.  We find selective inhibition of only PI3Kδ is weakly anti-inflammatory, but PI3Kδ/γ inhibitors show superior inflammatory marker suppression through suppression of lipopolysaccharide-induced TNFα prodn. and T cell activation.  Moreover, PI3Kδ/γ inhibition yields an anti-inflammatory signature distinct from pan-PI3K inhibition and known anti-inflammatory drugs, yet bears striking similarities to glucocorticoid receptor agonists.  These results highlight the potential of selectively designing drugs that target kinases with shared biol. function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9YDqq1G_IirVg90H21EOLACvtfcHk0li027pk0TREGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1Wksrc%253D&md5=a42b5b326cd3aebe67b0c5ce18bb66ca</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DKunkel%26aufirst%3DE.%2BJ.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDiscovery%2520of%2520dual%2520inhibitors%2520of%2520the%2520immune%2520cell%2520PI3Ks%2520p110delta%2520and%2520p110gamma%253A%2520a%2520prototype%2520for%2520new%2520anti-inflammatory%2520drugs%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26issue%3D2%26spage%3D123%26epage%3D134%26doi%3D10.1016%2Fj.chembiol.2010.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, T.</span></span> <span> </span><span class="NLM_article-title">Prediction of efficacious inhalation lung doses via the use of in silico lung retention quantitative structure-activity relationship models and <i>in vitro</i> potency screens</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2218</span>– <span class="NLM_lpage">2225</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.034462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1124%2Fdmd.110.034462" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2218-2225&author=A.+Cooperauthor=T.+Potterauthor=T.+Luker&title=Prediction+of+efficacious+inhalation+lung+doses+via+the+use+of+in+silico+lung+retention+quantitative+structure-activity+relationship+models+and+in+vitro+potency+screens&doi=10.1124%2Fdmd.110.034462"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.034462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.034462%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DT.%26aulast%3DLuker%26aufirst%3DT.%26atitle%3DPrediction%2520of%2520efficacious%2520inhalation%2520lung%2520doses%2520via%2520the%2520use%2520of%2520in%2520silico%2520lung%2520retention%2520quantitative%2520structure-activity%2520relationship%2520models%2520and%2520in%2520vitro%2520potency%2520screens%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D2218%26epage%3D2225%26doi%3D10.1124%2Fdmd.110.034462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenwaelder, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlencordt, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzker, R.</span></span> <span> </span><span class="NLM_article-title">Overlapping and distinct roles for PI3Kβ and γ isoforms in S1P-induced migration of human and mouse en-dothelial cells</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1093/cvr/cvn159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1093%2Fcvr%2Fcvn159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=96-105&author=R.+Hellerauthor=Q.+Changauthor=G.+Ehrlichauthor=S.+N.+Hsiehauthor=S.+M.+Schoenwaelderauthor=P.+J.+Kuhlencordtauthor=K.+T.+Preissnerauthor=E.+Hirschauthor=R.+Wetzker&title=Overlapping+and+distinct+roles+for+PI3K%CE%B2+and+%CE%B3+isoforms+in+S1P-induced+migration+of+human+and+mouse+en-dothelial+cells&doi=10.1093%2Fcvr%2Fcvn159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fcvr%2Fcvn159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcvr%252Fcvn159%26sid%3Dliteratum%253Aachs%26aulast%3DHeller%26aufirst%3DR.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DEhrlich%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DS.%2BN.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DKuhlencordt%26aufirst%3DP.%2BJ.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DWetzker%26aufirst%3DR.%26atitle%3DOverlapping%2520and%2520distinct%2520roles%2520for%2520PI3K%25CE%25B2%2520and%2520%25CE%25B3%2520isoforms%2520in%2520S1P-induced%2520migration%2520of%2520human%2520and%2520mouse%2520en-dothelial%2520cells%26jtitle%3DCardiovasc.%2520Res.%26date%3D2008%26volume%3D80%26spage%3D96%26epage%3D105%26doi%3D10.1093%2Fcvr%2Fcvn159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snider, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Amine-induced rearrangement of 4-imino-4<i>H</i>-3,1-benzoxazines to 4-quinazolinones via amidine carboxamides</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.3987/COM-03-S12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.3987%2FCOM-03-S12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=173-182&author=B.+B.+Sniderauthor=H.+Zeng&title=Amine-induced+rearrangement+of+4-imino-4H-3%2C1-benzoxazines+to+4-quinazolinones+via+amidine+carboxamides&doi=10.3987%2FCOM-03-S12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3987%2FCOM-03-S12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-03-S12%26sid%3Dliteratum%253Aachs%26aulast%3DSnider%26aufirst%3DB.%2BB.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DAmine-induced%2520rearrangement%2520of%25204-imino-4H-3%252C1-benzoxazines%2520to%25204-quinazolinones%2520via%2520amidine%2520carboxamides%26jtitle%3DHeterocycles%26date%3D2003%26volume%3D61%26spage%3D173%26epage%3D182%26doi%3D10.3987%2FCOM-03-S12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':[],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng Li, Xiaofei Liang, Zongru Jiang, Aoli Wang, Junjie Wang, Cheng Chen, Wenliang Wang, Fengming Zou, Ziping Qi, Qingwang Liu, Zhenquan Hu, Jiangyan Cao, Hong Wu, Beilei Wang, Li Wang, Jing Liu, <span class="NLM_string-name hlFld-ContribAuthor">Qingsong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13973-13993. <a href="https://doi.org/10.1021/acs.jmedchem.0c01544" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528S%252529-2-%2525281-%2525284-Amino-3-%2525283-fluoro-4-methoxyphenyl%252529-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-1-yl%252529propyl%252529-3-cyclopropyl-5-fluoroquinazolin-4%2525283H%252529-one%252B%252528IHMT-PI3K%2525CE%2525B4-372%252529%252Bas%252Ba%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DLi%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03092020%26date%3D12112020%26volume%3D63%26issue%3D22%26spage%3D13973%26epage%3D13993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Debasmita Saha, Anupreet Kharbanda, Wei Yan, Naga Rajiv Lakkaniga, Brendan Frett, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">The Exploration of Chirality for Improved Druggability within the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 441-469. <a href="https://doi.org/10.1021/acs.jmedchem.9b00640" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00640%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BExploration%252Bof%252BChirality%252Bfor%252BImproved%252BDruggability%252Bwithin%252Bthe%252BHuman%252BKinome%26aulast%3DSaha%26aufirst%3DDebasmita%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D15042019%26date%3D09102019%26date%3D24092019%26volume%3D63%26issue%3D2%26spage%3D441%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eddy W. Yue, Yun-Long Li, Brent Douty, Chunhong He, Song Mei, Brian Wayland, Thomas Maduskuie, Nikoo Falahatpisheh, Richard B. Sparks, Padmaja Polam, Wenyu Zhu, Joseph Glenn, Hao Feng, Ke Zhang, Yanlong Li, Xin He, Kamna Katiyar, Maryanne Covington, Patricia Feldman, Niu Shin, Kathy He Wang, Sharon Diamond, Yu Li, Holly K. Koblish, Leslie Hall, Peggy Scherle, Swamy Yeleswaram, Chu-Biao Xue, Brian Metcalf, Andrew P. Combs, <span class="NLM_string-name hlFld-ContribAuthor">Wenqing Yao</span>. </span><span class="cited-content_cbyCitation_article-title">INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (11)
                                     , 1554-1560. <a href="https://doi.org/10.1021/acsmedchemlett.9b00334" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00334%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DINCB050465%252B%252528Parsaclisib%252529%25252C%252Ba%252BNovel%252BNext-Generation%252BInhibitor%252Bof%252BPhosphoinositide%252B3-Kinase%252BDelta%252B%252528PI3K%2525CE%2525B4%252529%26aulast%3DYue%26aufirst%3DEddy%2BW.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28082019%26date%3D17102019%26date%3D24102019%26date%3D17102019%26volume%3D10%26issue%3D11%26spage%3D1554%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengbin  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyue  Xu</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Tianze  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Hong</span>, <span class="hlFld-ContribAuthor ">Mingzhu  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Jia</span>, <span class="hlFld-ContribAuthor ">Yongtai  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Mingli  Deng</span>, <span class="hlFld-ContribAuthor ">Zhenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Qingquan  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Ling</span>, <span class="hlFld-ContribAuthor ">Yaming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric replacements of the indole moiety for the development of a potent and selective PI3Kδ inhibitor: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113661. <a href="https://doi.org/10.1016/j.ejmech.2021.113661" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113661%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioisosteric%252Breplacements%252Bof%252Bthe%252Bindole%252Bmoiety%252Bfor%252Bthe%252Bdevelopment%252Bof%252Ba%252Bpotent%252Band%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitor%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DYang%26aufirst%3DChengbin%26date%3D2021%26volume%3D223%26spage%3D113661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luciana Pádua  Tavares</span>, <span class="hlFld-ContribAuthor ">Izabela  Galvão</span>, <span class="hlFld-ContribAuthor ">Maximiliano R  Ferrero</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Immunomodulatory Therapies for Respiratory Pathologies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00073-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00073-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00073-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00073-6%26sid%3Dliteratum%253Aachs%26atitle%3DNovel%252BImmunomodulatory%252BTherapies%252Bfor%252BRespiratory%252BPathologies%26aulast%3DTavares%26aufirst%3DLuciana%2BP%25C3%25A1dua%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Sun</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yuan  Huang</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>. </span><span class="cited-content_cbyCitation_article-title">Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127457. <a href="https://doi.org/10.1016/j.bmcl.2020.127457" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127457%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DResearch%252Badvances%252Bon%252Bselective%252Bphosphatidylinositol%252B3%252Bkinase%252B%2525CE%2525B4%252B%252528PI3K%2525CE%2525B4%252529%252Binhibitors%26aulast%3DSun%26aufirst%3DJiajia%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Qing  Jia</span>, <span class="hlFld-ContribAuthor ">Ya-Ya  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Feng</span>, <span class="hlFld-ContribAuthor ">Wei-Ren  Xu</span>, <span class="hlFld-ContribAuthor ">Xian-Chao  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel and highly selective PI3Kδ inhibitors based on the p110δ crystal structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (8)
                                     , 2499-2508. <a href="https://doi.org/10.1080/07391102.2019.1635531" title="DOI URL">https://doi.org/10.1080/07391102.2019.1635531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1635531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1635531%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDiscovery%252Bof%252Bnovel%252Band%252Bhighly%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitors%252Bbased%252Bon%252Bthe%252Bp110%2525CE%2525B4%252Bcrystal%252Bstructure%26aulast%3DJia%26aufirst%3DWen-Qing%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D8%26spage%3D2499%26epage%3D2508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Naomi S.  Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126658. <a href="https://doi.org/10.1016/j.bmcl.2019.126658" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126658%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhaled%252BJanus%252BKinase%252B%252528JAK%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Miller</span>, <span class="hlFld-ContribAuthor ">Philip  Thompson</span>, <span class="hlFld-ContribAuthor ">Sandra  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of Isoform Selectivity in PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 82. <a href="https://doi.org/10.3390/biom9030082" title="DOI URL">https://doi.org/10.3390/biom9030082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9030082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9030082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructural%252BDeterminants%252Bof%252BIsoform%252BSelectivity%252Bin%252BPI3K%252BInhibitors%26aulast%3DMiller%26aufirst%3DMichelle%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arduino  Mangoni</span>, <span class="hlFld-ContribAuthor ">Catherine  Guillou</span>, <span class="hlFld-ContribAuthor ">Jean  Vanden Eynde</span>, <span class="hlFld-ContribAuthor ">Christopher  Hulme</span>, <span class="hlFld-ContribAuthor ">Josef  Jampilek</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Katalin  Prokai-Tatrai</span>, <span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Maria  Sousa</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Sabatier</span>, <span class="hlFld-ContribAuthor ">Stefania  Galdiero</span>, <span class="hlFld-ContribAuthor ">Rafik  Karaman</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>, <span class="hlFld-ContribAuthor ">Giangiacomo  Torri</span>, <span class="hlFld-ContribAuthor ">F.  Luque</span>, <span class="hlFld-ContribAuthor ">M.  Vasconcelos</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>, <span class="hlFld-ContribAuthor ">Carlo  Siciliano</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Rino  Ragno</span>, <span class="hlFld-ContribAuthor ">Paula  Gomes</span>, <span class="hlFld-ContribAuthor ">Luigi  Agrofoglio</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–4. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1)
                                     , 130. <a href="https://doi.org/10.3390/molecules24010130" title="DOI URL">https://doi.org/10.3390/molecules24010130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24010130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24010130%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBreakthroughs%252Bin%252BMedicinal%252BChemistry%25253A%252BNew%252BTargets%252Band%252BMechanisms%25252C%252BNew%252BDrugs%25252C%252BNew%252BHopes%2525E2%252580%2525934%26aulast%3DMangoni%26aufirst%3DArduino%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D1%26spage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Pyrrolotriazinone Scaffold</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray co-crystal structure of the binding pocket of human PI3Kδ-containing compound <b>1</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U">5M6U</a>). Hydrogen bonds are colored in green dotted lines and the location of the affinity pocket is shown by the blue circle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray co-crystal structure of the binding pocket of human PI3Kδ-containing compound <b>39</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W">6G6W</a>). Hydrogen bonds are colored in green dotted lines and distances are shown in blue (Å).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of the relationship between dose-normalized lung exposure (AUC/dose) and the amount of compound recovered in the lung (expressed as percentage of dose) at the first kinetic time point after administration. The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Purple line corresponds with a dose-normalized lung exposure of 100 μg·h/g and the blue line corresponds with the amount of compound recovered in the lung (expressed as percent of dose) of 50% at the first kinetic time point after administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of the dose-normalized lung exposure (AUC/dose) for each compound versus the lung/plasma ratio at equilibrium (1 h after administration). The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Blue lines correspond with lung/plasma ratios of 100 and 1000 at 1 h after compound administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plot of the relationship between PAMPA (expressed as 10<sup>–6</sup> cm/s) and dose-normalized lung exposure (AUC/dose) for each compound. The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Blue line corresponds with a dose-normalized lung exposure of 50 μg·h/g and the purple line corresponds with a PAMPA of 1 × 10<sup>–6</sup> cm/s.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Relationship between theoretical polar surface area (TPSA) and molecular weight (MW) versus lung exposure. The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Blue lines correspond with a molecular weight of 550 Da and a theoretical polar surface area of 150.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Plot of the relationship between the number of hydrogen-bond donors (HBDs) versus dose-normalized lung exposure (AUC/Dose). The figure was produced using Vortex. Color indicates compound series (red for series A, green for series B). Dose-normalized lung exposure is represented in the <i>y</i>-axis and the number of hydrogen-bond donors in the <i>x</i>-axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Time course of compound recovery from lung tissue after i.t. administration of different compounds at 0.015 mg/kg in solution. The figure was produced using GraphPad Prism 7. Colors indicate the number of hydrogen-bonds donors present in each compound (blue for 3 HBD, red for 4 HBD, and green for 5HBD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Inhibition of inflammatory cell infiltration in the OVA rat model after i.t. administration of LAS195319. Inhibition of inflammatory cell infiltration was studied measuring neutrophils (A) and eosinophils (B) in BALF induced by OVA challenge in a Brown Norway rat model after i.t. administration of LAS195319. Two independent experiments were performed (<i>n</i> = 11–16 per dose). One way ANOVA and Dunnett’s test with *, ***, **** indicating <i>P</i> < 0.05, 0,001, and 0,0001 versus vehicle + OVA group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Amino Intermediate <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) oxalyl chloride, DCM; (b) aniline, DIPEA, DCM; (c) NaClO, NaOH, NH<sub>4</sub>OH, NH<sub>4</sub>Cl, water/MTBE, <i>N</i>-methyl-<i>N</i>,<i>N</i>-dioctyloctan-1-aminium chloride; (d) <i>N</i>-Boc-Ala, 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (PPACA), DIEA, EtOAc; (e) PPh<sub>3</sub>, Br<sub>2</sub>, TEA, DCM; (f) NH<sub>3</sub>/MeOH; (g) TFA, DCM.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to Compounds <b>14</b>–<b>26</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CsF, DIEA, tBuOH; (b) Ar–B(OH)<sub>2</sub> or Ar-Bpin, PdCl<sub>2</sub>dppf·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane; (c) Ar–CH<sub>2</sub>–Bpin, PdCl<sub>2</sub>dppf·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane; (d) Ar-SH, CuI, K<sub>2</sub>CO<sub>3</sub>, DCM; (e) DIEA, EtOH; (f) LiOH, THF/EtOH/water; (g) ArNH<sub>2</sub>, HATU, DIEA, DMF; (h) TFA.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Compounds <b>32</b>–<b>47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CsF, DIEA, tBuOH; (b) Ar–B(OH)<sub>2</sub> or Ar-Bpin, PdCl<sub>2</sub>dppf·DCM or PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> or Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME/water or DMF; (c) 1. TFA or BBr<sub>3</sub>/DCM 2. NH<sub>3</sub>/MeOH; (d) DIEA, <i>t</i>BuOH; (e) H<sub>2</sub>, 10% Pd/C, MeOH; (f) ArNH<sub>2</sub>, PPACA, DIEA, EtOAc.</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/medium/jm-2018-00873r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to LAS195319<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00873/20181101/images/large/jm-2018-00873r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00873&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) PdCl<sub>2</sub>dppf·DCM, Na<sub>2</sub>CO<sub>3</sub>, DME/water; (b) ClSO<sub>2</sub>NH<sub>2</sub>, pyridine, THF; (c) (1) TFA, (2) NH<sub>3</sub>/MeOH.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 12 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.</span></span> <span> </span><span class="NLM_article-title">PI3K signaling: the path to discovery and understanding</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/nrm3290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1038%2Fnrm3290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=22358332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1eqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=195-203&issue=3&author=B.+Vanhaesebroeckauthor=L.+Stephensauthor=P.+Hawkins&title=PI3K+signaling%3A+the+path+to+discovery+and+understanding&doi=10.1038%2Fnrm3290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K signalling: The path to discovery and understanding</span></div><div class="casAuthors">Vanhaesebroeck, Bart; Stephens, Len; Hawkins, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Over the past two decades, our understanding of phosphoinositide 3-kinases (PI3Ks) has progressed from the identification of an enzymic activity assocd. with growth factors, GPCRs and certain oncogene products to a disease target in cancer and inflammation, with PI3K inhibitors currently in clin. trials.  Elucidation of PI3K-dependent networks led to the discovery of the phosphoinositide-binding PH, PX and FYVE domains as conduits of intracellular lipid signalling, the detn. of the mol. function of the tumor suppressor PTEN and the identification of AKT and mTOR protein kinases as key regulators of cell growth.  Here we look back at the main discoveries that shaped the PI3K field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WDc7Z5rhLLVg90H21EOLACvtfcHk0licN1X6qDwB7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1eqt7s%253D&md5=ff960f9ebfb5b5f2d8fc214aba330eef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3290%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%26atitle%3DPI3K%2520signaling%253A%2520the%2520path%2520to%2520discovery%2520and%2520understanding%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26issue%3D3%26spage%3D195%26epage%3D203%26doi%3D10.1038%2Fnrm3290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affleck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span> <span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for allergic asthma</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1042/BST20110665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1042%2FBST20110665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=22260698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=240-245&issue=1&author=W.+C.+Rowanauthor=J.+L.+Smithauthor=K.+Affleckauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+allergic+asthma&doi=10.1042%2FBST20110665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for allergic asthma</span></div><div class="casAuthors">Rowan, Wendy C.; Smith, Janet L.; Affleck, Karen; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-245</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation in the lung has long been linked to the pathogenesis of asthma.  Central to this airway inflammation is a T-cell response to allergens, with Th2 cytokines driving the differentiation, survival and function of the major inflammatory cells involved in the allergic cascade.  PI3Kδ (phosphoinositide 3-kinase δ) is a lipid kinase, expressed predominantly in leukocytes, where it plays a crit. role in immune receptor signalling.  A selective PI3Kδ inhibitor is predicted to block T-cell activation in the lung, reducing the prodn. of pro-inflammatory Th2 cytokines.  PI3Kδ is also involved in B-cell and mast cell activation.  Therefore the inhibition of PI3Kδ should dampen down the inflammatory cascade involved in the asthmatic response through a wide breadth of pharmacol.  Current anti-inflammatory therapies, which are based on corticosteroids, are effective in controlling inflammation in mild asthmatics, but moderate/severe asthmatic patients remain poorly controlled, experiencing recurrent exacerbations.  Corticosteroids have no effect on mast cell degranulation and do not act directly on B-cells, so, overall, a PI3Kδ inhibitor has the potential to deliver improvements in onset of action, efficacy and reduced exacerbations in moderate/severe asthmatics.  Addnl., PI3Kδ inhibition is expected to block effects of Th17 cells, which are increasingly implicated in steroid-insensitive asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwu2SYlFjDbVg90H21EOLACvtfcHk0ljMxHG5g3c6Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D&md5=db36bc8f79c70e0817e00fb9b04f10ff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2FBST20110665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110665%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520allergic%2520asthma%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26issue%3D1%26spage%3D240%26epage%3D245%26doi%3D10.1042%2FBST20110665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sriskantharajah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calver, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessel, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span> <span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1280</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1111/nyas.12039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1111%2Fnyas.12039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=23551101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1280&publication_year=2013&pages=35-39&author=S.+Sriskantharajahauthor=N.+Hamblinauthor=S.+Worsleyauthor=A.+R.+Calverauthor=E.+M.+Hesselauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+the+treatment+of+respiratory+diseases&doi=10.1111%2Fnyas.12039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span></div><div class="casAuthors">Sriskantharajah, Srividya; Hamblin, Nicole; Worsley, Sally; Calver, Andrew R.; Hessel, Edith M.; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1280</span>
        (<span class="NLM_cas:issue">Inositol Phospholipid Signaling in Physiology and Disease</span>),
    <span class="NLM_cas:pages">35-39</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Asthma and chronic obstructive pulmonary disease (COPD) are characterized in their pathogenesis by chronic inflammation in the airways.  Phosphoinositide 3-kinase δ (PI3Kδ), a lipid kinase expressed predominantly in leukocytes, is thought to hold much promise as a therapeutic target for such inflammatory conditions.  Of particular interest for the treatment of severe respiratory disease is the observation that inhibition of PI3Kδ may restore steroid effectiveness under conditions of oxidative stress.  PI3Kδ inhibition may also prevent recruitment of inflammatory cells, including T lymphocytes and neutrophils, as well as the release of proinflammatory mediators, such as cytokines, chemokines, reactive oxygen species, and proteolytic enzymes.  In addn., targeting the PI3Kδ pathway could reduce the incidence of pathogen-induced exacerbations by improving macrophage-mediated bacterial clearance.  In this review, we discuss the potential and highlight the unknowns of targeting PI3Kδ for the treatment of respiratory disease, focusing on recent developments in the role of the PI3Kδ pathway in inflammatory cell types believed to be crit. to the pathogenesis of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa4PRY73w17Vg90H21EOLACvtfcHk0ljMxHG5g3c6Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D&md5=51549242bdf01d3373ded21565656f1d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fnyas.12039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.12039%26sid%3Dliteratum%253Aachs%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DHamblin%26aufirst%3DN.%26aulast%3DWorsley%26aufirst%3DS.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520the%2520treatment%2520of%2520respiratory%2520diseases%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1280%26spage%3D35%26epage%3D39%26doi%3D10.1111%2Fnyas.12039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="note"><p class="first last">Zydelig prescribing information.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span> <span> </span><span class="NLM_article-title">Optimisation of DMPK by inhaled route: Challenges and approaches</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=A.+E.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+inhaled+route%3A+Challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0ljMxHG5g3c6Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520inhaled%2520route%253A%2520Challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span>RV1729
and RV6153 (RespiVert) and GSK2269557 (GSK) at <a href="http://clinicaltrials.gov" class="extLink">clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=RV1729%0Aand+RV6153+%28RespiVert%29+and+GSK2269557+%28GSK%29+at+clinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gréco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caturla, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gràcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armengol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabedo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, M. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective, and orally available PI3Kδ inhibitor for the treatment of inflammatory diseases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=118-123&issue=1&author=M.+Erraauthor=J.+Taltavullauthor=A.+Gr%C3%A9coauthor=F.+J.+Bernalauthor=J.+F.+Caturlaauthor=J.+Gr%C3%A0ciaauthor=M.+Dom%C3%ADnguezauthor=M.+Sabat%C3%A9author=S.+Parisauthor=S.+Soriaauthor=B.+Hern%C3%A1ndezauthor=C.+Armengolauthor=J.+Cabedoauthor=M.+Bravoauthor=E.+Calamaauthor=M.+Miralpeixauthor=M.+D.+Lehner&title=Discovery+of+a+potent%2C+selective%2C+and+orally+available+PI3K%CE%B4+inhibitor+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facsmedchemlett.6b00438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00438%26sid%3Dliteratum%253Aachs%26aulast%3DErra%26aufirst%3DM.%26aulast%3DTaltavull%26aufirst%3DJ.%26aulast%3DGr%25C3%25A9co%26aufirst%3DA.%26aulast%3DBernal%26aufirst%3DF.%2BJ.%26aulast%3DCaturla%26aufirst%3DJ.%2BF.%26aulast%3DGr%25C3%25A0cia%26aufirst%3DJ.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DM.%26aulast%3DSabat%25C3%25A9%26aufirst%3DM.%26aulast%3DParis%26aufirst%3DS.%26aulast%3DSoria%26aufirst%3DS.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DArmengol%26aufirst%3DC.%26aulast%3DCabedo%26aufirst%3DJ.%26aulast%3DBravo%26aufirst%3DM.%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520PI3K%25CE%25B4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D118%26epage%3D123%26doi%3D10.1021%2Facsmedchemlett.6b00438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span> <span> </span><span class="NLM_article-title">The p110δ structure: mechanisms for selectivity and potency of new PI(3)k inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.+C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williamsauthor=P.+Ren&title=The+p110%CE%B4+structure%3A+mechanisms+for+selectivity+and+potency+of+new+PI%283%29k+inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0liH_9Zhh8DWmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DRen%26aufirst%3DP.%26atitle%3DThe%2520p110%25CE%25B4%2520structure%253A%2520mechanisms%2520for%2520selectivity%2520and%2520potency%2520of%2520new%2520PI%25283%2529k%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkel, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1016%2Fj.chembiol.2010.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=20189103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1Wksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=123-134&issue=2&author=O.+Williamsauthor=B.+T.+Housemanauthor=E.+J.+Kunkelauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=Z.+A.+Knightauthor=K.+M.+Shokat&title=Discovery+of+dual+inhibitors+of+the+immune+cell+PI3Ks+p110delta+and+p110gamma%3A+a+prototype+for+new+anti-inflammatory+drugs&doi=10.1016%2Fj.chembiol.2010.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Dual Inhibitors of the Immune Cell PI3Ks p110δ and p110γ: A Prototype for New Anti-inflammatory Drugs</span></div><div class="casAuthors">Williams, Olusegun; Houseman, Benjamin T.; Kunkel, Eric J.; Aizenstein, Brian; Hoffman, Randy; Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PI3Kδ and PI3Kγ regulate immune cell signaling, while the related PI3Kα and PI3Kβ regulate cell survival and metab.  Selective inhibitors of PI3Kδ/γ represent a potential class of anti-inflammatory agents lacking the antiproliferative effects assocd. with PI3Kα/β inhibition.  Here we report the discovery of PI3Kδ/γ inhibitors that display up to 1000-fold selectivity over PI3Kα/β and evaluate these compds. in a high-content inflammation assay using mixts. of primary human cells.  We find selective inhibition of only PI3Kδ is weakly anti-inflammatory, but PI3Kδ/γ inhibitors show superior inflammatory marker suppression through suppression of lipopolysaccharide-induced TNFα prodn. and T cell activation.  Moreover, PI3Kδ/γ inhibition yields an anti-inflammatory signature distinct from pan-PI3K inhibition and known anti-inflammatory drugs, yet bears striking similarities to glucocorticoid receptor agonists.  These results highlight the potential of selectively designing drugs that target kinases with shared biol. function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9YDqq1G_IirVg90H21EOLACvtfcHk0liH_9Zhh8DWmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1Wksrc%253D&md5=a42b5b326cd3aebe67b0c5ce18bb66ca</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DKunkel%26aufirst%3DE.%2BJ.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDiscovery%2520of%2520dual%2520inhibitors%2520of%2520the%2520immune%2520cell%2520PI3Ks%2520p110delta%2520and%2520p110gamma%253A%2520a%2520prototype%2520for%2520new%2520anti-inflammatory%2520drugs%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26issue%3D2%26spage%3D123%26epage%3D134%26doi%3D10.1016%2Fj.chembiol.2010.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, T.</span></span> <span> </span><span class="NLM_article-title">Prediction of efficacious inhalation lung doses via the use of in silico lung retention quantitative structure-activity relationship models and <i>in vitro</i> potency screens</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2218</span>– <span class="NLM_lpage">2225</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.034462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1124%2Fdmd.110.034462" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2218-2225&author=A.+Cooperauthor=T.+Potterauthor=T.+Luker&title=Prediction+of+efficacious+inhalation+lung+doses+via+the+use+of+in+silico+lung+retention+quantitative+structure-activity+relationship+models+and+in+vitro+potency+screens&doi=10.1124%2Fdmd.110.034462"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.034462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.034462%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DT.%26aulast%3DLuker%26aufirst%3DT.%26atitle%3DPrediction%2520of%2520efficacious%2520inhalation%2520lung%2520doses%2520via%2520the%2520use%2520of%2520in%2520silico%2520lung%2520retention%2520quantitative%2520structure-activity%2520relationship%2520models%2520and%2520in%2520vitro%2520potency%2520screens%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D2218%26epage%3D2225%26doi%3D10.1124%2Fdmd.110.034462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenwaelder, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlencordt, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzker, R.</span></span> <span> </span><span class="NLM_article-title">Overlapping and distinct roles for PI3Kβ and γ isoforms in S1P-induced migration of human and mouse en-dothelial cells</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1093/cvr/cvn159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.1093%2Fcvr%2Fcvn159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=96-105&author=R.+Hellerauthor=Q.+Changauthor=G.+Ehrlichauthor=S.+N.+Hsiehauthor=S.+M.+Schoenwaelderauthor=P.+J.+Kuhlencordtauthor=K.+T.+Preissnerauthor=E.+Hirschauthor=R.+Wetzker&title=Overlapping+and+distinct+roles+for+PI3K%CE%B2+and+%CE%B3+isoforms+in+S1P-induced+migration+of+human+and+mouse+en-dothelial+cells&doi=10.1093%2Fcvr%2Fcvn159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fcvr%2Fcvn159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcvr%252Fcvn159%26sid%3Dliteratum%253Aachs%26aulast%3DHeller%26aufirst%3DR.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DEhrlich%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DS.%2BN.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DKuhlencordt%26aufirst%3DP.%2BJ.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DWetzker%26aufirst%3DR.%26atitle%3DOverlapping%2520and%2520distinct%2520roles%2520for%2520PI3K%25CE%25B2%2520and%2520%25CE%25B3%2520isoforms%2520in%2520S1P-induced%2520migration%2520of%2520human%2520and%2520mouse%2520en-dothelial%2520cells%26jtitle%3DCardiovasc.%2520Res.%26date%3D2008%26volume%3D80%26spage%3D96%26epage%3D105%26doi%3D10.1093%2Fcvr%2Fcvn159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snider, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Amine-induced rearrangement of 4-imino-4<i>H</i>-3,1-benzoxazines to 4-quinazolinones via amidine carboxamides</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.3987/COM-03-S12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;key=10.3987%2FCOM-03-S12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=173-182&author=B.+B.+Sniderauthor=H.+Zeng&title=Amine-induced+rearrangement+of+4-imino-4H-3%2C1-benzoxazines+to+4-quinazolinones+via+amidine+carboxamides&doi=10.3987%2FCOM-03-S12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3987%2FCOM-03-S12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-03-S12%26sid%3Dliteratum%253Aachs%26aulast%3DSnider%26aufirst%3DB.%2BB.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DAmine-induced%2520rearrangement%2520of%25204-imino-4H-3%252C1-benzoxazines%2520to%25204-quinazolinones%2520via%2520amidine%2520carboxamides%26jtitle%3DHeterocycles%26date%3D2003%26volume%3D61%26spage%3D173%26epage%3D182%26doi%3D10.3987%2FCOM-03-S12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U','PDB','5M6U'); return false;">PDB: 5M6U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W','PDB','6G6W'); return false;">PDB: 6G6W</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00873">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33572"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00873">10.1021/acs.jmedchem.8b00873</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_001.csv">CSV</a>)</p></li><li><p class="inline">Assays procedures, full selectivity panel for compound <b>50</b>, and characterization data for the most advanced compounds <b>15</b> and <b>50</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_001.csv">jm8b00873_si_001.csv (4.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00873/suppl_file/jm8b00873_si_002.pdf">jm8b00873_si_002.pdf (766.97 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors are deposited in the Protein Data Bank and will be released upon publication. PDB IDs have been provided in figure legends (<b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6U">5M6U</a>; <b>39</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G6W">6G6W</a>)</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00873&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00873%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00873" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799badbed693d82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
